'en:sebaceous epithelioma'
(id=6707360 ; fe=en:sebaceous epithelioma ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=51167 creation date=2017-06-21 touchdate=2025-09-04 20:01:33.000) ≈ 572 relations sortantes
- en:sebaceous epithelioma --
r_associated #0: 41 / 1 ->
en:benign neoplasm of eyelid including canthus
n1=en:sebaceous epithelioma | n2=en:benign neoplasm of eyelid including canthus | rel=r_associated | relid=0 | w=41
- en:sebaceous epithelioma --
r_associated #0: 35 / 0.854 ->
en:accelerated neoplasm growth
n1=en:sebaceous epithelioma | n2=en:accelerated neoplasm growth | rel=r_associated | relid=0 | w=35
- en:sebaceous epithelioma --
r_associated #0: 35 / 0.854 ->
en:benign neoplasm: skin of other and unspecified parts of face
n1=en:sebaceous epithelioma | n2=en:benign neoplasm: skin of other and unspecified parts of face | rel=r_associated | relid=0 | w=35
- en:sebaceous epithelioma --
r_associated #0: 35 / 0.854 ->
en:brain neoplasm
n1=en:sebaceous epithelioma | n2=en:brain neoplasm | rel=r_associated | relid=0 | w=35
- en:sebaceous epithelioma --
r_associated #0: 35 / 0.854 ->
en:malignant neoplasm
n1=en:sebaceous epithelioma | n2=en:malignant neoplasm | rel=r_associated | relid=0 | w=35
- en:sebaceous epithelioma --
r_associated #0: 34 / 0.829 ->
en:benign neoplasm of scalp and skin of neck
n1=en:sebaceous epithelioma | n2=en:benign neoplasm of scalp and skin of neck | rel=r_associated | relid=0 | w=34
- en:sebaceous epithelioma --
r_associated #0: 34 / 0.829 ->
en:benign neoplasm of skin of lip
n1=en:sebaceous epithelioma | n2=en:benign neoplasm of skin of lip | rel=r_associated | relid=0 | w=34
- en:sebaceous epithelioma --
r_associated #0: 34 / 0.829 ->
en:carcinoma in situ
n1=en:sebaceous epithelioma | n2=en:carcinoma in situ | rel=r_associated | relid=0 | w=34
- en:sebaceous epithelioma --
r_associated #0: 34 / 0.829 ->
en:malignant spindle cell neoplasm
n1=en:sebaceous epithelioma | n2=en:malignant spindle cell neoplasm | rel=r_associated | relid=0 | w=34
- en:sebaceous epithelioma --
r_associated #0: 32 / 0.78 ->
en:neoplasm of unspecified nature of respiratory system
n1=en:sebaceous epithelioma | n2=en:neoplasm of unspecified nature of respiratory system | rel=r_associated | relid=0 | w=32
- en:sebaceous epithelioma --
r_associated #0: 31 / 0.756 ->
en:benign neoplasm of skin of upper limb or shoulder nos
n1=en:sebaceous epithelioma | n2=en:benign neoplasm of skin of upper limb or shoulder nos | rel=r_associated | relid=0 | w=31
- en:sebaceous epithelioma --
r_associated #0: 31 / 0.756 ->
en:neoplasm of unspecified nature of other genitourinary organs
n1=en:sebaceous epithelioma | n2=en:neoplasm of unspecified nature of other genitourinary organs | rel=r_associated | relid=0 | w=31
- en:sebaceous epithelioma --
r_associated #0: 31 / 0.756 ->
en:neoplasm/cancer invasiveness
n1=en:sebaceous epithelioma | n2=en:neoplasm/cancer invasiveness | rel=r_associated | relid=0 | w=31
- en:sebaceous epithelioma --
r_associated #0: 31 / 0.756 ->
en:neoplasms of uncertain or unknown behaviour
n1=en:sebaceous epithelioma | n2=en:neoplasms of uncertain or unknown behaviour | rel=r_associated | relid=0 | w=31
- en:sebaceous epithelioma --
r_associated #0: 30 / 0.732 ->
en:blood vessel neoplasm
n1=en:sebaceous epithelioma | n2=en:blood vessel neoplasm | rel=r_associated | relid=0 | w=30
- en:sebaceous epithelioma --
r_associated #0: 30 / 0.732 ->
en:neoplasm of unspecified nature of bone, soft tissue, and skin
n1=en:sebaceous epithelioma | n2=en:neoplasm of unspecified nature of bone, soft tissue, and skin | rel=r_associated | relid=0 | w=30
- en:sebaceous epithelioma --
r_associated #0: 30 / 0.732 ->
en:neoplasm, uncertain whether benign or malignant
n1=en:sebaceous epithelioma | n2=en:neoplasm, uncertain whether benign or malignant | rel=r_associated | relid=0 | w=30
- en:sebaceous epithelioma --
r_associated #0: 30 / 0.732 ->
poumon
n1=en:sebaceous epithelioma | n2=poumon | rel=r_associated | relid=0 | w=30
- en:sebaceous epithelioma --
r_associated #0: 29 / 0.707 ->
en:benign fibrous histiocytoma
n1=en:sebaceous epithelioma | n2=en:benign fibrous histiocytoma | rel=r_associated | relid=0 | w=29
- en:sebaceous epithelioma --
r_associated #0: 29 / 0.707 ->
en:fibrous skin tumor of tuberous sclerosis
n1=en:sebaceous epithelioma | n2=en:fibrous skin tumor of tuberous sclerosis | rel=r_associated | relid=0 | w=29
- en:sebaceous epithelioma --
r_associated #0: 29 / 0.707 ->
en:kidney wilms tumor
n1=en:sebaceous epithelioma | n2=en:kidney wilms tumor | rel=r_associated | relid=0 | w=29
- en:sebaceous epithelioma --
r_associated #0: 29 / 0.707 ->
en:malignant neoplasm of lip, oral cavity and pharynx
n1=en:sebaceous epithelioma | n2=en:malignant neoplasm of lip, oral cavity and pharynx | rel=r_associated | relid=0 | w=29
- en:sebaceous epithelioma --
r_associated #0: 29 / 0.707 ->
en:malignant neoplasms of respiratory and intrathoracic organs
n1=en:sebaceous epithelioma | n2=en:malignant neoplasms of respiratory and intrathoracic organs | rel=r_associated | relid=0 | w=29
- en:sebaceous epithelioma --
r_associated #0: 29 / 0.707 ->
en:malignant tumor of lymphoid hemopoietic and related tissue
n1=en:sebaceous epithelioma | n2=en:malignant tumor of lymphoid hemopoietic and related tissue | rel=r_associated | relid=0 | w=29
- en:sebaceous epithelioma --
r_associated #0: 29 / 0.707 ->
en:malignant tumor, small cell type
n1=en:sebaceous epithelioma | n2=en:malignant tumor, small cell type | rel=r_associated | relid=0 | w=29
- en:sebaceous epithelioma --
r_associated #0: 29 / 0.707 ->
en:oropharyngeal squamous cell carcinoma
n1=en:sebaceous epithelioma | n2=en:oropharyngeal squamous cell carcinoma | rel=r_associated | relid=0 | w=29
- en:sebaceous epithelioma --
r_associated #0: 29 / 0.707 ->
en:skin tag
n1=en:sebaceous epithelioma | n2=en:skin tag | rel=r_associated | relid=0 | w=29
- en:sebaceous epithelioma --
r_associated #0: 28 / 0.683 ->
en:benign endocrine neoplasm
n1=en:sebaceous epithelioma | n2=en:benign endocrine neoplasm | rel=r_associated | relid=0 | w=28
- en:sebaceous epithelioma --
r_associated #0: 28 / 0.683 ->
en:carotid body paraganglioma
n1=en:sebaceous epithelioma | n2=en:carotid body paraganglioma | rel=r_associated | relid=0 | w=28
- en:sebaceous epithelioma --
r_associated #0: 28 / 0.683 ->
en:malignant cell
n1=en:sebaceous epithelioma | n2=en:malignant cell | rel=r_associated | relid=0 | w=28
- en:sebaceous epithelioma --
r_associated #0: 28 / 0.683 ->
en:tumor cells, benign
n1=en:sebaceous epithelioma | n2=en:tumor cells, benign | rel=r_associated | relid=0 | w=28
- en:sebaceous epithelioma --
r_associated #0: 27 / 0.659 ->
en:benign male reproductive system neoplasm
n1=en:sebaceous epithelioma | n2=en:benign male reproductive system neoplasm | rel=r_associated | relid=0 | w=27
- en:sebaceous epithelioma --
r_associated #0: 27 / 0.659 ->
en:benign neoplasm
n1=en:sebaceous epithelioma | n2=en:benign neoplasm | rel=r_associated | relid=0 | w=27
- en:sebaceous epithelioma --
r_associated #0: 27 / 0.659 ->
en:benign neoplasm of skin of head and neck
n1=en:sebaceous epithelioma | n2=en:benign neoplasm of skin of head and neck | rel=r_associated | relid=0 | w=27
- en:sebaceous epithelioma --
r_associated #0: 27 / 0.659 ->
en:in situ neoplasm (morphology)
n1=en:sebaceous epithelioma | n2=en:in situ neoplasm (morphology) | rel=r_associated | relid=0 | w=27
- en:sebaceous epithelioma --
r_associated #0: 27 / 0.659 ->
en:lobular hemangioma
n1=en:sebaceous epithelioma | n2=en:lobular hemangioma | rel=r_associated | relid=0 | w=27
- en:sebaceous epithelioma --
r_associated #0: 27 / 0.659 ->
en:lymphatic vessel neoplasm
n1=en:sebaceous epithelioma | n2=en:lymphatic vessel neoplasm | rel=r_associated | relid=0 | w=27
- en:sebaceous epithelioma --
r_associated #0: 27 / 0.659 ->
en:malignant neoplasm of digestive organs and peritoneum
n1=en:sebaceous epithelioma | n2=en:malignant neoplasm of digestive organs and peritoneum | rel=r_associated | relid=0 | w=27
- en:sebaceous epithelioma --
r_associated #0: 27 / 0.659 ->
en:malignant peripheral nerve sheath tumor
n1=en:sebaceous epithelioma | n2=en:malignant peripheral nerve sheath tumor | rel=r_associated | relid=0 | w=27
- en:sebaceous epithelioma --
r_associated #0: 27 / 0.659 ->
en:ovarian sex cord-stromal tumor
n1=en:sebaceous epithelioma | n2=en:ovarian sex cord-stromal tumor | rel=r_associated | relid=0 | w=27
- en:sebaceous epithelioma --
r_associated #0: 26 / 0.634 ->
carcinome endométrial
n1=en:sebaceous epithelioma | n2=carcinome endométrial | rel=r_associated | relid=0 | w=26
- en:sebaceous epithelioma --
r_associated #0: 26 / 0.634 ->
en:ampulla of vater adenocarcinoma
n1=en:sebaceous epithelioma | n2=en:ampulla of vater adenocarcinoma | rel=r_associated | relid=0 | w=26
- en:sebaceous epithelioma --
r_associated #0: 26 / 0.634 ->
en:becker nevus
n1=en:sebaceous epithelioma | n2=en:becker nevus | rel=r_associated | relid=0 | w=26
- en:sebaceous epithelioma --
r_associated #0: 26 / 0.634 ->
en:endometrial carcinoma
n1=en:sebaceous epithelioma | n2=en:endometrial carcinoma | rel=r_associated | relid=0 | w=26
- en:sebaceous epithelioma --
r_associated #0: 26 / 0.634 ->
en:infected naevus
n1=en:sebaceous epithelioma | n2=en:infected naevus | rel=r_associated | relid=0 | w=26
- en:sebaceous epithelioma --
r_associated #0: 26 / 0.634 ->
en:lung
n1=en:sebaceous epithelioma | n2=en:lung | rel=r_associated | relid=0 | w=26
- en:sebaceous epithelioma --
r_associated #0: 26 / 0.634 ->
en:myopericytoma of skin
n1=en:sebaceous epithelioma | n2=en:myopericytoma of skin | rel=r_associated | relid=0 | w=26
- en:sebaceous epithelioma --
r_associated #0: 26 / 0.634 ->
en:nervous system neoplasms malignant and unspecified nec
n1=en:sebaceous epithelioma | n2=en:nervous system neoplasms malignant and unspecified nec | rel=r_associated | relid=0 | w=26
- en:sebaceous epithelioma --
r_associated #0: 26 / 0.634 ->
en:rhabdomyosarcoma
n1=en:sebaceous epithelioma | n2=en:rhabdomyosarcoma | rel=r_associated | relid=0 | w=26
- en:sebaceous epithelioma --
r_associated #0: 25 / 0.61 ->
carcinome de l'endomètre
n1=en:sebaceous epithelioma | n2=carcinome de l'endomètre | rel=r_associated | relid=0 | w=25
- en:sebaceous epithelioma --
r_associated #0: 25 / 0.61 ->
en:benign neoplasm of skin of hip and lower limb
n1=en:sebaceous epithelioma | n2=en:benign neoplasm of skin of hip and lower limb | rel=r_associated | relid=0 | w=25
- en:sebaceous epithelioma --
r_associated #0: 25 / 0.61 ->
en:lung adenocarcinoma
n1=en:sebaceous epithelioma | n2=en:lung adenocarcinoma | rel=r_associated | relid=0 | w=25
- en:sebaceous epithelioma --
r_associated #0: 24 / 0.585 ->
en:chordoma
n1=en:sebaceous epithelioma | n2=en:chordoma | rel=r_associated | relid=0 | w=24
- en:sebaceous epithelioma --
r_associated #0: 24 / 0.585 ->
en:myomatous neoplasm
n1=en:sebaceous epithelioma | n2=en:myomatous neoplasm | rel=r_associated | relid=0 | w=24
- en:sebaceous epithelioma --
r_associated #0: 24 / 0.585 ->
en:neoplastic cell
n1=en:sebaceous epithelioma | n2=en:neoplastic cell | rel=r_associated | relid=0 | w=24
- en:sebaceous epithelioma --
r_associated #0: 24 / 0.585 ->
en:sebaceoma
n1=en:sebaceous epithelioma | n2=en:sebaceoma | rel=r_associated | relid=0 | w=24
- en:sebaceous epithelioma --
r_associated #0: 24 / 0.585 ->
méningiome
n1=en:sebaceous epithelioma | n2=méningiome | rel=r_associated | relid=0 | w=24
- en:sebaceous epithelioma --
r_associated #0: 23 / 0.561 ->
en:benign tumor of dermis
n1=en:sebaceous epithelioma | n2=en:benign tumor of dermis | rel=r_associated | relid=0 | w=23
- en:sebaceous epithelioma --
r_associated #0: 23 / 0.561 ->
en:fibrosarcoma
n1=en:sebaceous epithelioma | n2=en:fibrosarcoma | rel=r_associated | relid=0 | w=23
- en:sebaceous epithelioma --
r_associated #0: 23 / 0.561 ->
en:metastatic angiosarcoma
n1=en:sebaceous epithelioma | n2=en:metastatic angiosarcoma | rel=r_associated | relid=0 | w=23
- en:sebaceous epithelioma --
r_associated #0: 23 / 0.561 ->
en:multinucleate cell angiohistiocytoma
n1=en:sebaceous epithelioma | n2=en:multinucleate cell angiohistiocytoma | rel=r_associated | relid=0 | w=23
- en:sebaceous epithelioma --
r_associated #0: 23 / 0.561 ->
en:radiation-related neoplasm
n1=en:sebaceous epithelioma | n2=en:radiation-related neoplasm | rel=r_associated | relid=0 | w=23
- en:sebaceous epithelioma --
r_associated #0: 23 / 0.561 ->
en:seborrheic keratosis
n1=en:sebaceous epithelioma | n2=en:seborrheic keratosis | rel=r_associated | relid=0 | w=23
- en:sebaceous epithelioma --
r_associated #0: 23 / 0.561 ->
néoplasme malin
n1=en:sebaceous epithelioma | n2=néoplasme malin | rel=r_associated | relid=0 | w=23
- en:sebaceous epithelioma --
r_associated #0: 22 / 0.537 ->
en:malignant skin neoplasm
n1=en:sebaceous epithelioma | n2=en:malignant skin neoplasm | rel=r_associated | relid=0 | w=22
- en:sebaceous epithelioma --
r_associated #0: 22 / 0.537 ->
en:meningioma
n1=en:sebaceous epithelioma | n2=en:meningioma | rel=r_associated | relid=0 | w=22
- en:sebaceous epithelioma --
r_associated #0: 22 / 0.537 ->
en:plasma cell myeloma
n1=en:sebaceous epithelioma | n2=en:plasma cell myeloma | rel=r_associated | relid=0 | w=22
- en:sebaceous epithelioma --
r_associated #0: 22 / 0.537 ->
en:skin - benign mole and nevus
n1=en:sebaceous epithelioma | n2=en:skin - benign mole and nevus | rel=r_associated | relid=0 | w=22
- en:sebaceous epithelioma --
r_associated #0: 22 / 0.537 ->
hémangiome
n1=en:sebaceous epithelioma | n2=hémangiome | rel=r_associated | relid=0 | w=22
- en:sebaceous epithelioma --
r_associated #0: 21 / 0.512 ->
en:benign neoplasm of skin of ear and external auditory meatus
n1=en:sebaceous epithelioma | n2=en:benign neoplasm of skin of ear and external auditory meatus | rel=r_associated | relid=0 | w=21
- en:sebaceous epithelioma --
r_associated #0: 21 / 0.512 ->
en:benign skin neoplasm
n1=en:sebaceous epithelioma | n2=en:benign skin neoplasm | rel=r_associated | relid=0 | w=21
- en:sebaceous epithelioma --
r_associated #0: 21 / 0.512 ->
en:osteosarcoma
n1=en:sebaceous epithelioma | n2=en:osteosarcoma | rel=r_associated | relid=0 | w=21
- en:sebaceous epithelioma --
r_associated #0: 21 / 0.512 ->
en:sarcoma
n1=en:sebaceous epithelioma | n2=en:sarcoma | rel=r_associated | relid=0 | w=21
- en:sebaceous epithelioma --
r_associated #0: 21 / 0.512 ->
en:sebaceous adenoma of skin
n1=en:sebaceous epithelioma | n2=en:sebaceous adenoma of skin | rel=r_associated | relid=0 | w=21
- en:sebaceous epithelioma --
r_associated #0: 21 / 0.512 ->
en:sweat gland neoplasm
n1=en:sebaceous epithelioma | n2=en:sweat gland neoplasm | rel=r_associated | relid=0 | w=21
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
acrochordon
n1=en:sebaceous epithelioma | n2=acrochordon | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
adenocarcinoma
n1=en:sebaceous epithelioma | n2=adenocarcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
adénocarcinome
n1=en:sebaceous epithelioma | n2=adénocarcinome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
Adénocarcinome
n1=en:sebaceous epithelioma | n2=Adénocarcinome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
adénocarcinome du côlon
n1=en:sebaceous epithelioma | n2=adénocarcinome du côlon | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
adénome à cellules oncocytaires
n1=en:sebaceous epithelioma | n2=adénome à cellules oncocytaires | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
adénome malin
n1=en:sebaceous epithelioma | n2=adénome malin | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
adénome oncocytaire
n1=en:sebaceous epithelioma | n2=adénome oncocytaire | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
adénosarcome sébacé
n1=en:sebaceous epithelioma | n2=adénosarcome sébacé | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
angiome
n1=en:sebaceous epithelioma | n2=angiome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
blastome
n1=en:sebaceous epithelioma | n2=blastome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
cancer à cellules claires du rein
n1=en:sebaceous epithelioma | n2=cancer à cellules claires du rein | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
cancer colique
n1=en:sebaceous epithelioma | n2=cancer colique | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
cancer colo-rectal
n1=en:sebaceous epithelioma | n2=cancer colo-rectal | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
cancer colorectal
n1=en:sebaceous epithelioma | n2=cancer colorectal | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
cancer cutané
n1=en:sebaceous epithelioma | n2=cancer cutané | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
cancer de l'endomètre
n1=en:sebaceous epithelioma | n2=cancer de l'endomètre | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
cancer de l'oesophage
n1=en:sebaceous epithelioma | n2=cancer de l'oesophage | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
cancer de la peau
n1=en:sebaceous epithelioma | n2=cancer de la peau | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
Cancer de la peau
n1=en:sebaceous epithelioma | n2=Cancer de la peau | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
cancer du duodénum
n1=en:sebaceous epithelioma | n2=cancer du duodénum | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
cancer du pancréas
n1=en:sebaceous epithelioma | n2=cancer du pancréas | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
Cancer du pancréas
n1=en:sebaceous epithelioma | n2=Cancer du pancréas | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
cancer du sang
n1=en:sebaceous epithelioma | n2=cancer du sang | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
cancer du sein
n1=en:sebaceous epithelioma | n2=cancer du sein | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
cancer duodénal
n1=en:sebaceous epithelioma | n2=cancer duodénal | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
cancer embryonnaire
n1=en:sebaceous epithelioma | n2=cancer embryonnaire | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
cancer endométrial
n1=en:sebaceous epithelioma | n2=cancer endométrial | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
cancer glandulaire
n1=en:sebaceous epithelioma | n2=cancer glandulaire | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
cancer oesophagien
n1=en:sebaceous epithelioma | n2=cancer oesophagien | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
cancer pancréatique
n1=en:sebaceous epithelioma | n2=cancer pancréatique | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
cancer sébacé
n1=en:sebaceous epithelioma | n2=cancer sébacé | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
cancers
n1=en:sebaceous epithelioma | n2=cancers | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
carcinome colo-rectal
n1=en:sebaceous epithelioma | n2=carcinome colo-rectal | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
carcinome colorectal
n1=en:sebaceous epithelioma | n2=carcinome colorectal | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
carcinome du gros intestin
n1=en:sebaceous epithelioma | n2=carcinome du gros intestin | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
carcinome du pancreas
n1=en:sebaceous epithelioma | n2=carcinome du pancreas | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
carcinome du pancréas
n1=en:sebaceous epithelioma | n2=carcinome du pancréas | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
carcinome glandulaire
n1=en:sebaceous epithelioma | n2=carcinome glandulaire | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
carcinome pancréatique
n1=en:sebaceous epithelioma | n2=carcinome pancréatique | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
carcinome recto-colique
n1=en:sebaceous epithelioma | n2=carcinome recto-colique | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
carcinome rectocolique
n1=en:sebaceous epithelioma | n2=carcinome rectocolique | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
carcinome sébacé
n1=en:sebaceous epithelioma | n2=carcinome sébacé | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
cellule tumorale
n1=en:sebaceous epithelioma | n2=cellule tumorale | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
chordome
n1=en:sebaceous epithelioma | n2=chordome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
dermatofibrome
n1=en:sebaceous epithelioma | n2=dermatofibrome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
dysgerminome
n1=en:sebaceous epithelioma | n2=dysgerminome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:abdominal tumors (immunodeficiency-associated form)
n1=en:sebaceous epithelioma | n2=en:abdominal tumors (immunodeficiency-associated form) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:acinar cell neoplasm
n1=en:sebaceous epithelioma | n2=en:acinar cell neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:acrochordon
n1=en:sebaceous epithelioma | n2=en:acrochordon | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:acute lymphoblastic leukemia
n1=en:sebaceous epithelioma | n2=en:acute lymphoblastic leukemia | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:acute lymphoblastic leukemia (in 1 patient)
n1=en:sebaceous epithelioma | n2=en:acute lymphoblastic leukemia (in 1 patient) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:acute megakaryoblastic leukemia
n1=en:sebaceous epithelioma | n2=en:acute megakaryoblastic leukemia | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:acute monocytic leukemia
n1=en:sebaceous epithelioma | n2=en:acute monocytic leukemia | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:acute myeloblastic leukaemia
n1=en:sebaceous epithelioma | n2=en:acute myeloblastic leukaemia | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:acute myeloblastic leukemia
n1=en:sebaceous epithelioma | n2=en:acute myeloblastic leukemia | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:acute myeloid leukemia
n1=en:sebaceous epithelioma | n2=en:acute myeloid leukemia | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:adenocarcinoma
n1=en:sebaceous epithelioma | n2=en:adenocarcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:adenocarcinoma of colon
n1=en:sebaceous epithelioma | n2=en:adenocarcinoma of colon | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:adnexal and/or skin appendage neoplasm
n1=en:sebaceous epithelioma | n2=en:adnexal and/or skin appendage neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:adrenal cortex carcinoma
n1=en:sebaceous epithelioma | n2=en:adrenal cortex carcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:adrenal gland pheochromocytoma
n1=en:sebaceous epithelioma | n2=en:adrenal gland pheochromocytoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:alveolar cell carcinoma (some)
n1=en:sebaceous epithelioma | n2=en:alveolar cell carcinoma (some) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:angiomatous meningioma
n1=en:sebaceous epithelioma | n2=en:angiomatous meningioma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:angioneoplasm
n1=en:sebaceous epithelioma | n2=en:angioneoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:astrocytoma, increased risk of
n1=en:sebaceous epithelioma | n2=en:astrocytoma, increased risk of | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:b-cell acute lymphoblastic leukemia (in some patients)
n1=en:sebaceous epithelioma | n2=en:b-cell acute lymphoblastic leukemia (in some patients) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:b-cell non-hodgkin lymphoma
n1=en:sebaceous epithelioma | n2=en:b-cell non-hodgkin lymphoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:basal cell nevus
n1=en:sebaceous epithelioma | n2=en:basal cell nevus | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:basocellular neoplasms
n1=en:sebaceous epithelioma | n2=en:basocellular neoplasms | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:basocellular neoplasms develop after second decade
n1=en:sebaceous epithelioma | n2=en:basocellular neoplasms develop after second decade | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:benign digestive system neoplasm
n1=en:sebaceous epithelioma | n2=en:benign digestive system neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:benign female reproductive system neoplasm
n1=en:sebaceous epithelioma | n2=en:benign female reproductive system neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:benign growth
n1=en:sebaceous epithelioma | n2=en:benign growth | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:benign hair follicle neoplasm
n1=en:sebaceous epithelioma | n2=en:benign hair follicle neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:benign soft tissue neoplasm
n1=en:sebaceous epithelioma | n2=en:benign soft tissue neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:benign tumor
n1=en:sebaceous epithelioma | n2=en:benign tumor | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:benign tumors of the eye, heart, and lungs
n1=en:sebaceous epithelioma | n2=en:benign tumors of the eye, heart, and lungs | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:benign tumour
n1=en:sebaceous epithelioma | n2=en:benign tumour | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:birt-hogg-dube syndrome
n1=en:sebaceous epithelioma | n2=en:birt-hogg-dube syndrome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:bladder urothelial carcinoma
n1=en:sebaceous epithelioma | n2=en:bladder urothelial carcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:blue nevus
n1=en:sebaceous epithelioma | n2=en:blue nevus | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:bone metastases from squamous cell carcinoma
n1=en:sebaceous epithelioma | n2=en:bone metastases from squamous cell carcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:bone neoplasm
n1=en:sebaceous epithelioma | n2=en:bone neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:bone-forming neoplasm
n1=en:sebaceous epithelioma | n2=en:bone-forming neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:bowenoid papulosis
n1=en:sebaceous epithelioma | n2=en:bowenoid papulosis | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:breast cancer (rare)
n1=en:sebaceous epithelioma | n2=en:breast cancer (rare) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:breast cancer, early-onset (in some patients)
n1=en:sebaceous epithelioma | n2=en:breast cancer, early-onset (in some patients) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:breast carcinoma
n1=en:sebaceous epithelioma | n2=en:breast carcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:breast neoplasms benign (incl nipple)
n1=en:sebaceous epithelioma | n2=en:breast neoplasms benign (incl nipple) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:bronchogenic carcinoma (some)
n1=en:sebaceous epithelioma | n2=en:bronchogenic carcinoma (some) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:burkitt lymphoma (b-cell lymphoma)
n1=en:sebaceous epithelioma | n2=en:burkitt lymphoma (b-cell lymphoma) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:carotid body tumors (most common location)
n1=en:sebaceous epithelioma | n2=en:carotid body tumors (most common location) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:cervical cancer (rare)
n1=en:sebaceous epithelioma | n2=en:cervical cancer (rare) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:cervical carcinoma
n1=en:sebaceous epithelioma | n2=en:cervical carcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:chronic lymphocytic leukemia
n1=en:sebaceous epithelioma | n2=en:chronic lymphocytic leukemia | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:chronic lymphocytic leukemia, b-cell, susceptibility to
n1=en:sebaceous epithelioma | n2=en:chronic lymphocytic leukemia, b-cell, susceptibility to | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:classic hodgkin lymphoma
n1=en:sebaceous epithelioma | n2=en:classic hodgkin lymphoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:classic hodgkin lymphoma (in some patients)
n1=en:sebaceous epithelioma | n2=en:classic hodgkin lymphoma (in some patients) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:clear cell neoplasm
n1=en:sebaceous epithelioma | n2=en:clear cell neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:clear cell renal cell carcinoma
n1=en:sebaceous epithelioma | n2=en:clear cell renal cell carcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:colloid tumor
n1=en:sebaceous epithelioma | n2=en:colloid tumor | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:colon adenocarcinoma
n1=en:sebaceous epithelioma | n2=en:colon adenocarcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:colon carcinoma
n1=en:sebaceous epithelioma | n2=en:colon carcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:colonic neoplasms
n1=en:sebaceous epithelioma | n2=en:colonic neoplasms | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:colorectal cancer (in some patients)
n1=en:sebaceous epithelioma | n2=en:colorectal cancer (in some patients) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:colorectal cancer, early onset
n1=en:sebaceous epithelioma | n2=en:colorectal cancer, early onset | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:colorectal carcinoma
n1=en:sebaceous epithelioma | n2=en:colorectal carcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:compound nevus
n1=en:sebaceous epithelioma | n2=en:compound nevus | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:condyloma acuminatum
n1=en:sebaceous epithelioma | n2=en:condyloma acuminatum | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:cutaneous fibrous polyp
n1=en:sebaceous epithelioma | n2=en:cutaneous fibrous polyp | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:cutaneous granular cell tumor
n1=en:sebaceous epithelioma | n2=en:cutaneous granular cell tumor | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:cutaneous leiomyosarcoma (less common)
n1=en:sebaceous epithelioma | n2=en:cutaneous leiomyosarcoma (less common) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:cutaneous lipoma
n1=en:sebaceous epithelioma | n2=en:cutaneous lipoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:cylindromas may show malignant transformation
n1=en:sebaceous epithelioma | n2=en:cylindromas may show malignant transformation | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:cyst
n1=en:sebaceous epithelioma | n2=en:cyst | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:cystic, mucinous and/or serous neoplasm
n1=en:sebaceous epithelioma | n2=en:cystic, mucinous and/or serous neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:dermatofibroma
n1=en:sebaceous epithelioma | n2=en:dermatofibroma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:dermoid cyst of the skin
n1=en:sebaceous epithelioma | n2=en:dermoid cyst of the skin | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:desmocytoma
n1=en:sebaceous epithelioma | n2=en:desmocytoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:digestive system neoplasms
n1=en:sebaceous epithelioma | n2=en:digestive system neoplasms | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:duodenal cancer
n1=en:sebaceous epithelioma | n2=en:duodenal cancer | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:duodenal carcinoma
n1=en:sebaceous epithelioma | n2=en:duodenal carcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:dysgerminoma
n1=en:sebaceous epithelioma | n2=en:dysgerminoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:embryonal carcinoma
n1=en:sebaceous epithelioma | n2=en:embryonal carcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:endocrine neoplasms malignant and unspecified
n1=en:sebaceous epithelioma | n2=en:endocrine neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:endolymphatic sac tumor
n1=en:sebaceous epithelioma | n2=en:endolymphatic sac tumor | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:endometrial cancer
n1=en:sebaceous epithelioma | n2=en:endometrial cancer | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:enteropathy-associated t-cell lymphoma
n1=en:sebaceous epithelioma | n2=en:enteropathy-associated t-cell lymphoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:epithelial neoplasm
n1=en:sebaceous epithelioma | n2=en:epithelial neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:esophageal carcinoma
n1=en:sebaceous epithelioma | n2=en:esophageal carcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:extra-adrenal sympathetic paraganglioma
n1=en:sebaceous epithelioma | n2=en:extra-adrenal sympathetic paraganglioma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:eye neoplasm
n1=en:sebaceous epithelioma | n2=en:eye neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:fibroelastoma
n1=en:sebaceous epithelioma | n2=en:fibroelastoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:follicular lymphoma
n1=en:sebaceous epithelioma | n2=en:follicular lymphoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:frequent skin cancer
n1=en:sebaceous epithelioma | n2=en:frequent skin cancer | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:gangliocytoneuroma
n1=en:sebaceous epithelioma | n2=en:gangliocytoneuroma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:ganglioneuroma
n1=en:sebaceous epithelioma | n2=en:ganglioneuroma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:gastric adenocarcinoma
n1=en:sebaceous epithelioma | n2=en:gastric adenocarcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:gastrointestinal neoplasms malignant and unspecified
n1=en:sebaceous epithelioma | n2=en:gastrointestinal neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:gastrointestinal stromal tumors (less common)
n1=en:sebaceous epithelioma | n2=en:gastrointestinal stromal tumors (less common) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:giant cell astrocytoma
n1=en:sebaceous epithelioma | n2=en:giant cell astrocytoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:giant cell lesion of small bones
n1=en:sebaceous epithelioma | n2=en:giant cell lesion of small bones | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:giant cell tumor
n1=en:sebaceous epithelioma | n2=en:giant cell tumor | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:glandular carcinoma
n1=en:sebaceous epithelioma | n2=en:glandular carcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:glioma, increased risk of
n1=en:sebaceous epithelioma | n2=en:glioma, increased risk of | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:glioneuroma
n1=en:sebaceous epithelioma | n2=en:glioneuroma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:gonadoblastoma
n1=en:sebaceous epithelioma | n2=en:gonadoblastoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:granular cell tumor and/or alveolar soft part sarcoma
n1=en:sebaceous epithelioma | n2=en:granular cell tumor and/or alveolar soft part sarcoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:growth hormone-producing pituitary gland neoplasm
n1=en:sebaceous epithelioma | n2=en:growth hormone-producing pituitary gland neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:haematopoietic neoplasms (excl leukaemias and lymphomas)
n1=en:sebaceous epithelioma | n2=en:haematopoietic neoplasms (excl leukaemias and lymphomas) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:halo nevus
n1=en:sebaceous epithelioma | n2=en:halo nevus | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:head and neck paraganglioma
n1=en:sebaceous epithelioma | n2=en:head and neck paraganglioma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:hemangioma
n1=en:sebaceous epithelioma | n2=en:hemangioma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:hematopoietic and lymphoid cell neoplasm
n1=en:sebaceous epithelioma | n2=en:hematopoietic and lymphoid cell neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:hepatobiliary neoplasms malignant and unspecified
n1=en:sebaceous epithelioma | n2=en:hepatobiliary neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:hepatocellular carcinoma, childhood onset (reported in 2 patients)
n1=en:sebaceous epithelioma | n2=en:hepatocellular carcinoma, childhood onset (reported in 2 patients) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:hereditary neoplastic syndrome
n1=en:sebaceous epithelioma | n2=en:hereditary neoplastic syndrome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:histiocytoma, benign fibrous
n1=en:sebaceous epithelioma | n2=en:histiocytoma, benign fibrous | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:Hodgkin lymphoma
n1=en:sebaceous epithelioma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:hodgkin lymphoma
n1=en:sebaceous epithelioma | n2=en:hodgkin lymphoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:hypothalamic neoplasm
n1=en:sebaceous epithelioma | n2=en:hypothalamic neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased hepatocellular carcinoma risk
n1=en:sebaceous epithelioma | n2=en:increased hepatocellular carcinoma risk | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased incidence of hepatocellular carcinoma
n1=en:sebaceous epithelioma | n2=en:increased incidence of hepatocellular carcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased incidence of rectosigmoid cancer
n1=en:sebaceous epithelioma | n2=en:increased incidence of rectosigmoid cancer | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased malignancy risk, especially lymphoma and skin neoplasm
n1=en:sebaceous epithelioma | n2=en:increased malignancy risk, especially lymphoma and skin neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased risk for cancer
n1=en:sebaceous epithelioma | n2=en:increased risk for cancer | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased risk for hematologic cancer, particularly acute myeloid leukemia
n1=en:sebaceous epithelioma | n2=en:increased risk for hematologic cancer, particularly acute myeloid leukemia | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased risk for multiple myeloma
n1=en:sebaceous epithelioma | n2=en:increased risk for multiple myeloma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased risk in heterozygotes
n1=en:sebaceous epithelioma | n2=en:increased risk in heterozygotes | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased risk of breast cancer in women
n1=en:sebaceous epithelioma | n2=en:increased risk of breast cancer in women | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased risk of chondrosarcoma
n1=en:sebaceous epithelioma | n2=en:increased risk of chondrosarcoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased risk of chondrosarcoma (mean age of onset 31 years)
n1=en:sebaceous epithelioma | n2=en:increased risk of chondrosarcoma (mean age of onset 31 years) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased risk of endometrial cancer
n1=en:sebaceous epithelioma | n2=en:increased risk of endometrial cancer | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased risk of gastrointestinal cancer
n1=en:sebaceous epithelioma | n2=en:increased risk of gastrointestinal cancer | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased risk of giant cell tumor of bone
n1=en:sebaceous epithelioma | n2=en:increased risk of giant cell tumor of bone | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased risk of hematologic malignancy (1 patient)
n1=en:sebaceous epithelioma | n2=en:increased risk of hematologic malignancy (1 patient) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased risk of leukemia
n1=en:sebaceous epithelioma | n2=en:increased risk of leukemia | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased risk of malignancy
n1=en:sebaceous epithelioma | n2=en:increased risk of malignancy | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased risk of malignancy (classic feature)
n1=en:sebaceous epithelioma | n2=en:increased risk of malignancy (classic feature) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased risk of meningioma
n1=en:sebaceous epithelioma | n2=en:increased risk of meningioma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased risk of myelodysplastic syndromes
n1=en:sebaceous epithelioma | n2=en:increased risk of myelodysplastic syndromes | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased risk of other cancers (e.g., kidney cancer, lung cancer, and leukemia)
n1=en:sebaceous epithelioma | n2=en:increased risk of other cancers (e.g., kidney cancer, lung cancer, and leukemia) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased risk of pancreatic cancer
n1=en:sebaceous epithelioma | n2=en:increased risk of pancreatic cancer | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased risk of testicular cancer
n1=en:sebaceous epithelioma | n2=en:increased risk of testicular cancer | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased risk of tumor formation, especially of the head
n1=en:sebaceous epithelioma | n2=en:increased risk of tumor formation, especially of the head | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased susceptibility to cancer
n1=en:sebaceous epithelioma | n2=en:increased susceptibility to cancer | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased susceptibility to carcinomas, especially cancers related to cutaneous viral infections
n1=en:sebaceous epithelioma | n2=en:increased susceptibility to carcinomas, especially cancers related to cutaneous viral infections | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased susceptibility to hematologic malignancies
n1=en:sebaceous epithelioma | n2=en:increased susceptibility to hematologic malignancies | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased susceptibility to juvenile myelomonocytic leukemia
n1=en:sebaceous epithelioma | n2=en:increased susceptibility to juvenile myelomonocytic leukemia | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased susceptibility to malignancy
n1=en:sebaceous epithelioma | n2=en:increased susceptibility to malignancy | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:increased susceptibility to multiple carcinomas
n1=en:sebaceous epithelioma | n2=en:increased susceptibility to multiple carcinomas | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:innocent tumor
n1=en:sebaceous epithelioma | n2=en:innocent tumor | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:intradermal nevus
n1=en:sebaceous epithelioma | n2=en:intradermal nevus | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:jaw and kidney tumor (endemic form)
n1=en:sebaceous epithelioma | n2=en:jaw and kidney tumor (endemic form) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:jugulotympanic paraganglioma
n1=en:sebaceous epithelioma | n2=en:jugulotympanic paraganglioma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:junctional nevus
n1=en:sebaceous epithelioma | n2=en:junctional nevus | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:juvenile ovarian granulosa cell tumor
n1=en:sebaceous epithelioma | n2=en:juvenile ovarian granulosa cell tumor | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:kaposi sarcoma (1 patient)
n1=en:sebaceous epithelioma | n2=en:kaposi sarcoma (1 patient) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:laryngeal carcinoma
n1=en:sebaceous epithelioma | n2=en:laryngeal carcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:leser-trélat sign
n1=en:sebaceous epithelioma | n2=en:leser-trélat sign | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:leucemia
n1=en:sebaceous epithelioma | n2=en:leucemia | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:leukaemia
n1=en:sebaceous epithelioma | n2=en:leukaemia | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:leukemia
n1=en:sebaceous epithelioma | n2=en:leukemia | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:leukocythemia
n1=en:sebaceous epithelioma | n2=en:leukocythemia | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:lipoma
n1=en:sebaceous epithelioma | n2=en:lipoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:lipomatous neoplasm
n1=en:sebaceous epithelioma | n2=en:lipomatous neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:low incidence of plexiform neurofibromas
n1=en:sebaceous epithelioma | n2=en:low incidence of plexiform neurofibromas | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:low-grade neuroendocrine carcinoma (submandibular glands, salivary glands, maxillary sinus, nasal cavity)
n1=en:sebaceous epithelioma | n2=en:low-grade neuroendocrine carcinoma (submandibular glands, salivary glands, maxillary sinus, nasal cavity) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:lymphoproliferative disorder
n1=en:sebaceous epithelioma | n2=en:lymphoproliferative disorder | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:male germ cell tumors (gct), 2 subtypes -
n1=en:sebaceous epithelioma | n2=en:male germ cell tumors (gct), 2 subtypes - | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:malignancy in approximately 10%
n1=en:sebaceous epithelioma | n2=en:malignancy in approximately 10% | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:malignant breast neoplasm
n1=en:sebaceous epithelioma | n2=en:malignant breast neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:malignant central nervous system neoplasm
n1=en:sebaceous epithelioma | n2=en:malignant central nervous system neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:malignant colon neoplasm
n1=en:sebaceous epithelioma | n2=en:malignant colon neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:malignant digestive system neoplasm
n1=en:sebaceous epithelioma | n2=en:malignant digestive system neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:malignant esophageal neoplasm
n1=en:sebaceous epithelioma | n2=en:malignant esophageal neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:malignant fibrous histiocytoma (in about 35% of patients)
n1=en:sebaceous epithelioma | n2=en:malignant fibrous histiocytoma (in about 35% of patients) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:malignant genitourinary tract tumor
n1=en:sebaceous epithelioma | n2=en:malignant genitourinary tract tumor | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:malignant neoplasm of bone, connective tissue, skin and breast
n1=en:sebaceous epithelioma | n2=en:malignant neoplasm of bone, connective tissue, skin and breast | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:malignant neoplasm of skin
n1=en:sebaceous epithelioma | n2=en:malignant neoplasm of skin | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:malignant pancreatic neoplasm
n1=en:sebaceous epithelioma | n2=en:malignant pancreatic neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:malignant peripheral nerve sheath tumors (21%)
n1=en:sebaceous epithelioma | n2=en:malignant peripheral nerve sheath tumors (21%) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:malignant pharyngeal neoplasm
n1=en:sebaceous epithelioma | n2=en:malignant pharyngeal neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:malignant sex cord-stromal tumor
n1=en:sebaceous epithelioma | n2=en:malignant sex cord-stromal tumor | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:malignant thyroid gland neoplasm
n1=en:sebaceous epithelioma | n2=en:malignant thyroid gland neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:malignant transformation of choroid plexus papilloma
n1=en:sebaceous epithelioma | n2=en:malignant transformation of choroid plexus papilloma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:malignant tumor of colon
n1=en:sebaceous epithelioma | n2=en:malignant tumor of colon | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:malignant tumor, clear cell type
n1=en:sebaceous epithelioma | n2=en:malignant tumor, clear cell type | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:mammary ductal fibroadenoma
n1=en:sebaceous epithelioma | n2=en:mammary ductal fibroadenoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:melanocytic neoplasm
n1=en:sebaceous epithelioma | n2=en:melanocytic neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:melanoma
n1=en:sebaceous epithelioma | n2=en:melanoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:mesothelial neoplasm
n1=en:sebaceous epithelioma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:mesothelioma
n1=en:sebaceous epithelioma | n2=en:mesothelioma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:mesothelioma, malignant, after asbestos exposure
n1=en:sebaceous epithelioma | n2=en:mesothelioma, malignant, after asbestos exposure | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:miscellaneous and site unspecified neoplasms malignant and unspecified
n1=en:sebaceous epithelioma | n2=en:miscellaneous and site unspecified neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:monomorphic cells, medium-sized, with round nuclei, multiple nucleoli, and moderate amount of cytoplasm
n1=en:sebaceous epithelioma | n2=en:monomorphic cells, medium-sized, with round nuclei, multiple nucleoli, and moderate amount of cytoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:mucosal neuromas
n1=en:sebaceous epithelioma | n2=en:mucosal neuromas | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:mucous tumor
n1=en:sebaceous epithelioma | n2=en:mucous tumor | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:muir-torre syndrome
n1=en:sebaceous epithelioma | n2=en:muir-torre syndrome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:multiple bilateral renal angiomyolipoma
n1=en:sebaceous epithelioma | n2=en:multiple bilateral renal angiomyolipoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:multiple giant cell granulomas (bones, joints, soft tissues)
n1=en:sebaceous epithelioma | n2=en:multiple giant cell granulomas (bones, joints, soft tissues) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:multiple schwannomas
n1=en:sebaceous epithelioma | n2=en:multiple schwannomas | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:multiple tumors
n1=en:sebaceous epithelioma | n2=en:multiple tumors | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:multiple tumors in 28% of patients
n1=en:sebaceous epithelioma | n2=en:multiple tumors in 28% of patients | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:multiple tumors in 74% of patients
n1=en:sebaceous epithelioma | n2=en:multiple tumors in 74% of patients | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:myelogeneous leukemia, chronic
n1=en:sebaceous epithelioma | n2=en:myelogeneous leukemia, chronic | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:myocardial rhabdomyoma
n1=en:sebaceous epithelioma | n2=en:myocardial rhabdomyoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:myxoblastoma
n1=en:sebaceous epithelioma | n2=en:myxoblastoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:myxoid subcutaneous tumors
n1=en:sebaceous epithelioma | n2=en:myxoid subcutaneous tumors | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:myxoma
n1=en:sebaceous epithelioma | n2=en:myxoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:neoplasm by morphology
n1=en:sebaceous epithelioma | n2=en:neoplasm by morphology | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:neoplasm of perivascular myoid type - category
n1=en:sebaceous epithelioma | n2=en:neoplasm of perivascular myoid type - category | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:neoplasm of uncertain behavior of endocrine glands and nervous system
n1=en:sebaceous epithelioma | n2=en:neoplasm of uncertain behavior of endocrine glands and nervous system | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:neoplasm of uncertain behavior of other and unspecified sites and tissues
n1=en:sebaceous epithelioma | n2=en:neoplasm of uncertain behavior of other and unspecified sites and tissues | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:neoplasm of uncertain behavior of other specified sites
n1=en:sebaceous epithelioma | n2=en:neoplasm of uncertain behavior of other specified sites | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:neoplasm related morbidities
n1=en:sebaceous epithelioma | n2=en:neoplasm related morbidities | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:neoplasms by histologic type
n1=en:sebaceous epithelioma | n2=en:neoplasms by histologic type | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:neoplasms of unspecified nature or uncertain behavior
n1=en:sebaceous epithelioma | n2=en:neoplasms of unspecified nature or uncertain behavior | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:neoplasms, multiple primary
n1=en:sebaceous epithelioma | n2=en:neoplasms, multiple primary | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:neoplasms, post-traumatic
n1=en:sebaceous epithelioma | n2=en:neoplasms, post-traumatic | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:nervous system tumor morphology
n1=en:sebaceous epithelioma | n2=en:nervous system tumor morphology | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:neural tissue tumors
n1=en:sebaceous epithelioma | n2=en:neural tissue tumors | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:neurilemmoma
n1=en:sebaceous epithelioma | n2=en:neurilemmoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:neurinoma
n1=en:sebaceous epithelioma | n2=en:neurinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:neuroblastoma (less common)
n1=en:sebaceous epithelioma | n2=en:neuroblastoma (less common) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:neuroblastoma, arises anywhere along the sympathetic chain (including intracranially)
n1=en:sebaceous epithelioma | n2=en:neuroblastoma, arises anywhere along the sympathetic chain (including intracranially) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:neuroepitheliomatous neoplasm
n1=en:sebaceous epithelioma | n2=en:neuroepitheliomatous neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:neuroma
n1=en:sebaceous epithelioma | n2=en:neuroma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:neuronal or mixed neuronal-glial neoplasm
n1=en:sebaceous epithelioma | n2=en:neuronal or mixed neuronal-glial neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:no cancer despite harboring complete deletions of the tp53 gene
n1=en:sebaceous epithelioma | n2=en:no cancer despite harboring complete deletions of the tp53 gene | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:nonmedullary thyroid carcinoma (papillary and follicular)
n1=en:sebaceous epithelioma | n2=en:nonmedullary thyroid carcinoma (papillary and follicular) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:odontogenic neoplasm
n1=en:sebaceous epithelioma | n2=en:odontogenic neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:oligodendroglioma
n1=en:sebaceous epithelioma | n2=en:oligodendroglioma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:oncocytic adenoma
n1=en:sebaceous epithelioma | n2=en:oncocytic adenoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:optic glioma (19%)
n1=en:sebaceous epithelioma | n2=en:optic glioma (19%) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:optic nerve glioma
n1=en:sebaceous epithelioma | n2=en:optic nerve glioma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:osteoma cutis
n1=en:sebaceous epithelioma | n2=en:osteoma cutis | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:ovarian carcinoma
n1=en:sebaceous epithelioma | n2=en:ovarian carcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:ovarian cystadenoma
n1=en:sebaceous epithelioma | n2=en:ovarian cystadenoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:pancreas cancer
n1=en:sebaceous epithelioma | n2=en:pancreas cancer | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:pancreatic cancer
n1=en:sebaceous epithelioma | n2=en:pancreatic cancer | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:pancreatic carcinoma
n1=en:sebaceous epithelioma | n2=en:pancreatic carcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:pancreatic neoplasm
n1=en:sebaceous epithelioma | n2=en:pancreatic neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:pancreatic squamous cell carcinoma
n1=en:sebaceous epithelioma | n2=en:pancreatic squamous cell carcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:papillary neoplasm
n1=en:sebaceous epithelioma | n2=en:papillary neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:papillary renal cell adenoma
n1=en:sebaceous epithelioma | n2=en:papillary renal cell adenoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:papillary renal cell carcinoma
n1=en:sebaceous epithelioma | n2=en:papillary renal cell carcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:paraganglioma, catecholamine-secreting
n1=en:sebaceous epithelioma | n2=en:paraganglioma, catecholamine-secreting | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:paragangliomas, head and neck (31%)
n1=en:sebaceous epithelioma | n2=en:paragangliomas, head and neck (31%) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:paragangliomas, head and neck (79%)
n1=en:sebaceous epithelioma | n2=en:paragangliomas, head and neck (79%) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:paraneoplastic sps is associated with autoantibodies to amphiphysin (amph, 600418)
n1=en:sebaceous epithelioma | n2=en:paraneoplastic sps is associated with autoantibodies to amphiphysin (amph, 600418) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:parathyroid gland adenoma
n1=en:sebaceous epithelioma | n2=en:parathyroid gland adenoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:parathyroid gland carcinoma
n1=en:sebaceous epithelioma | n2=en:parathyroid gland carcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:parotid gland adenoma and adenocarcinoma
n1=en:sebaceous epithelioma | n2=en:parotid gland adenoma and adenocarcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:parotid gland monomorphic adenoma
n1=en:sebaceous epithelioma | n2=en:parotid gland monomorphic adenoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:parotid oncocytomas
n1=en:sebaceous epithelioma | n2=en:parotid oncocytomas | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:periampullary carcinoma nos
n1=en:sebaceous epithelioma | n2=en:periampullary carcinoma nos | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:pheochromocytoma, adrenal (53%)
n1=en:sebaceous epithelioma | n2=en:pheochromocytoma, adrenal (53%) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:pheochromocytoma, extraadrenal (21%)
n1=en:sebaceous epithelioma | n2=en:pheochromocytoma, extraadrenal (21%) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:pheochromocytomas, adrenal (28%)
n1=en:sebaceous epithelioma | n2=en:pheochromocytomas, adrenal (28%) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:pheochromocytomas, extraadrenal (48%)
n1=en:sebaceous epithelioma | n2=en:pheochromocytomas, extraadrenal (48%) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:phyllodes tumor
n1=en:sebaceous epithelioma | n2=en:phyllodes tumor | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:pigmented nevus
n1=en:sebaceous epithelioma | n2=en:pigmented nevus | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:pinealoma (trilateral retinoblastoma)
n1=en:sebaceous epithelioma | n2=en:pinealoma (trilateral retinoblastoma) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:pleomorphic benign salivary gland adenoma (psa)
n1=en:sebaceous epithelioma | n2=en:pleomorphic benign salivary gland adenoma (psa) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:precancerous condition
n1=en:sebaceous epithelioma | n2=en:precancerous condition | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:primary adrenocortical nodular hyperplasia
n1=en:sebaceous epithelioma | n2=en:primary adrenocortical nodular hyperplasia | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:propensity to tumor development
n1=en:sebaceous epithelioma | n2=en:propensity to tumor development | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:pyogenic granuloma of skin
n1=en:sebaceous epithelioma | n2=en:pyogenic granuloma of skin | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:rarely malignant
n1=en:sebaceous epithelioma | n2=en:rarely malignant | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:renal and urinary tract neoplasms malignant and unspecified
n1=en:sebaceous epithelioma | n2=en:renal and urinary tract neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:renal cortical adenoma
n1=en:sebaceous epithelioma | n2=en:renal cortical adenoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:reported colon and other abdominal cancer in relatives
n1=en:sebaceous epithelioma | n2=en:reported colon and other abdominal cancer in relatives | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:respiratory and mediastinal neoplasms benign (excl mesotheliomas)
n1=en:sebaceous epithelioma | n2=en:respiratory and mediastinal neoplasms benign (excl mesotheliomas) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:respiratory and mediastinal neoplasms malignant and unspecified
n1=en:sebaceous epithelioma | n2=en:respiratory and mediastinal neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:retinoblastoma
n1=en:sebaceous epithelioma | n2=en:retinoblastoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:rhabdoid tumors, malignant (renal or extrarenal)
n1=en:sebaceous epithelioma | n2=en:rhabdoid tumors, malignant (renal or extrarenal) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:sacrococcygeal teratoma
n1=en:sebaceous epithelioma | n2=en:sacrococcygeal teratoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:schwannoma
n1=en:sebaceous epithelioma | n2=en:schwannoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:sebaceous carcinoma
n1=en:sebaceous epithelioma | n2=en:sebaceous carcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:sex cord-stromal tumor
n1=en:sebaceous epithelioma | n2=en:sex cord-stromal tumor | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:signet ring cell carcinoma
n1=en:sebaceous epithelioma | n2=en:signet ring cell carcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:silicon granuloma
n1=en:sebaceous epithelioma | n2=en:silicon granuloma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:sinonasal undifferentiated carcinoma
n1=en:sebaceous epithelioma | n2=en:sinonasal undifferentiated carcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:skeletal neoplasms benign
n1=en:sebaceous epithelioma | n2=en:skeletal neoplasms benign | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:skeletal neoplasms malignant and unspecified
n1=en:sebaceous epithelioma | n2=en:skeletal neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:skin appendage tumors may show malignant transformation
n1=en:sebaceous epithelioma | n2=en:skin appendage tumors may show malignant transformation | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:skin basal cell carcinoma
n1=en:sebaceous epithelioma | n2=en:skin basal cell carcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:skin basal cell carcinoma with sebaceous differentiation
n1=en:sebaceous epithelioma | n2=en:skin basal cell carcinoma with sebaceous differentiation | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:skin cancer
n1=en:sebaceous epithelioma | n2=en:skin cancer | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:skin carcinoma
n1=en:sebaceous epithelioma | n2=en:skin carcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:skin cysts and polyps
n1=en:sebaceous epithelioma | n2=en:skin cysts and polyps | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:skin hemangioma
n1=en:sebaceous epithelioma | n2=en:skin hemangioma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:small cell carcinoma of the ovary, hypercalcemic type
n1=en:sebaceous epithelioma | n2=en:small cell carcinoma of the ovary, hypercalcemic type | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:small intestine carcinoid
n1=en:sebaceous epithelioma | n2=en:small intestine carcinoid | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:soft tissue neoplasms malignant and unspecified
n1=en:sebaceous epithelioma | n2=en:soft tissue neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:soft tissue tumor and/or sarcoma
n1=en:sebaceous epithelioma | n2=en:soft tissue tumor and/or sarcoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:somatostatin-producing neuroendocrine tumor
n1=en:sebaceous epithelioma | n2=en:somatostatin-producing neuroendocrine tumor | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:spindle cell sarcoma
n1=en:sebaceous epithelioma | n2=en:spindle cell sarcoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:spitz nevus
n1=en:sebaceous epithelioma | n2=en:spitz nevus | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:squamous cell carcinoma in area of palmoplantar keratoderma (rare)
n1=en:sebaceous epithelioma | n2=en:squamous cell carcinoma in area of palmoplantar keratoderma (rare) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:starry sky pattern
n1=en:sebaceous epithelioma | n2=en:starry sky pattern | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:statistical association of extensive metabolism (em, wildtype) and malignancy, especially smoking-induced lung cancer
n1=en:sebaceous epithelioma | n2=en:statistical association of extensive metabolism (em, wildtype) and malignancy, especially smoking-induced lung cancer | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:subependymoma
n1=en:sebaceous epithelioma | n2=en:subependymoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:susceptibility to malignant melanoma
n1=en:sebaceous epithelioma | n2=en:susceptibility to malignant melanoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:susceptibility to myelodysplasia
n1=en:sebaceous epithelioma | n2=en:susceptibility to myelodysplasia | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:susceptibility to myeloid leukemia
n1=en:sebaceous epithelioma | n2=en:susceptibility to myeloid leukemia | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:syringocystadenoma papilliferum
n1=en:sebaceous epithelioma | n2=en:syringocystadenoma papilliferum | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:teratoid tumor, atypical
n1=en:sebaceous epithelioma | n2=en:teratoid tumor, atypical | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:testicular sertoli cell tumor, calcified
n1=en:sebaceous epithelioma | n2=en:testicular sertoli cell tumor, calcified | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:thyroid cancer (follicular cell)
n1=en:sebaceous epithelioma | n2=en:thyroid cancer (follicular cell) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:thyroid cancer, follicular variant papillary
n1=en:sebaceous epithelioma | n2=en:thyroid cancer, follicular variant papillary | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:thyroid follicular cell tumor
n1=en:sebaceous epithelioma | n2=en:thyroid follicular cell tumor | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:thyroid gland oncocytic neoplasm
n1=en:sebaceous epithelioma | n2=en:thyroid gland oncocytic neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:thyroid gland papillary carcinoma
n1=en:sebaceous epithelioma | n2=en:thyroid gland papillary carcinoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:Tièche-Jadassohn's nevus
n1=en:sebaceous epithelioma | n2=en:Tièche-Jadassohn's nevus | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:tumor cell
n1=en:sebaceous epithelioma | n2=en:tumor cell | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:tumors at multiple other sites including cns
n1=en:sebaceous epithelioma | n2=en:tumors at multiple other sites including cns | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:tumors of the sympathetic nervous system (5 to 10%)
n1=en:sebaceous epithelioma | n2=en:tumors of the sympathetic nervous system (5 to 10%) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:unilateral vestibular schwannoma
n1=en:sebaceous epithelioma | n2=en:unilateral vestibular schwannoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:uterine leiomyosarcoma (less common)
n1=en:sebaceous epithelioma | n2=en:uterine leiomyosarcoma (less common) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
en:vestibular schwannoma (over 90% of patients)
n1=en:sebaceous epithelioma | n2=en:vestibular schwannoma (over 90% of patients) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
épithélioma sébacé
n1=en:sebaceous epithelioma | n2=épithélioma sébacé | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
état prénéoplasique
n1=en:sebaceous epithelioma | n2=état prénéoplasique | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
fibrome molluscum
n1=en:sebaceous epithelioma | n2=fibrome molluscum | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
fibrosarcome
n1=en:sebaceous epithelioma | n2=fibrosarcome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
ganglioneurome
n1=en:sebaceous epithelioma | n2=ganglioneurome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
gliome périphérique
n1=en:sebaceous epithelioma | n2=gliome périphérique | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
histiocytofibrome bénin
n1=en:sebaceous epithelioma | n2=histiocytofibrome bénin | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
histiocytome fibreux bénin
n1=en:sebaceous epithelioma | n2=histiocytome fibreux bénin | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
kératose séborrhéique
n1=en:sebaceous epithelioma | n2=kératose séborrhéique | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
la à granulocytes
n1=en:sebaceous epithelioma | n2=la à granulocytes | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
LA à granulocytes
n1=en:sebaceous epithelioma | n2=LA à granulocytes | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
lam
n1=en:sebaceous epithelioma | n2=lam | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
lanl
n1=en:sebaceous epithelioma | n2=lanl | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
lemmome
n1=en:sebaceous epithelioma | n2=lemmome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
leucémie
n1=en:sebaceous epithelioma | n2=leucémie | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
leucémie aiguë granulocytaire
n1=en:sebaceous epithelioma | n2=leucémie aiguë granulocytaire | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
leucémie aiguë myéloblastique
n1=en:sebaceous epithelioma | n2=leucémie aiguë myéloblastique | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
leucémie aigüe myéloblastique
n1=en:sebaceous epithelioma | n2=leucémie aigüe myéloblastique | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
leucémie aiguë myélocytaire
n1=en:sebaceous epithelioma | n2=leucémie aiguë myélocytaire | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
leucémie aiguë myéloïde
n1=en:sebaceous epithelioma | n2=leucémie aiguë myéloïde | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
leucémie aigüe myéloïde
n1=en:sebaceous epithelioma | n2=leucémie aigüe myéloïde | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
leucémie aigüe non lymphoblastique
n1=en:sebaceous epithelioma | n2=leucémie aigüe non lymphoblastique | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
leucémie aiguë non lymphoblastique
n1=en:sebaceous epithelioma | n2=leucémie aiguë non lymphoblastique | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
leucémie aiguë non lymphocytaire
n1=en:sebaceous epithelioma | n2=leucémie aiguë non lymphocytaire | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
leucémie blastique granulocytaire
n1=en:sebaceous epithelioma | n2=leucémie blastique granulocytaire | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
leucémie granuleuse aiguë
n1=en:sebaceous epithelioma | n2=leucémie granuleuse aiguë | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
leucémie granulocytaire aiguë
n1=en:sebaceous epithelioma | n2=leucémie granulocytaire aiguë | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
leucémie lymphoïde aiguë
n1=en:sebaceous epithelioma | n2=leucémie lymphoïde aiguë | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
leucémie lymphoïde chronique
n1=en:sebaceous epithelioma | n2=leucémie lymphoïde chronique | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
leucémie myéloblastique aigüe
n1=en:sebaceous epithelioma | n2=leucémie myéloblastique aigüe | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
leucémie myéloblastique aiguë
n1=en:sebaceous epithelioma | n2=leucémie myéloblastique aiguë | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
leucémie myélocytaire aiguë
n1=en:sebaceous epithelioma | n2=leucémie myélocytaire aiguë | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
leucémie myélogène aigüe
n1=en:sebaceous epithelioma | n2=leucémie myélogène aigüe | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
leucémie myélogène aiguë
n1=en:sebaceous epithelioma | n2=leucémie myélogène aiguë | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
leucémie myéloïde aiguë
n1=en:sebaceous epithelioma | n2=leucémie myéloïde aiguë | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
leucémie myéloïde aigüe
n1=en:sebaceous epithelioma | n2=leucémie myéloïde aigüe | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
leucémie non lymphoblastique aiguë
n1=en:sebaceous epithelioma | n2=leucémie non lymphoblastique aiguë | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
leucémies myéloïdes aiguës
n1=en:sebaceous epithelioma | n2=leucémies myéloïdes aiguës | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
lipome
n1=en:sebaceous epithelioma | n2=lipome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
lung
n1=en:sebaceous epithelioma | n2=lung | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
lymphome folliculaire
n1=en:sebaceous epithelioma | n2=lymphome folliculaire | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
maladie néoplasique maligne
n1=en:sebaceous epithelioma | n2=maladie néoplasique maligne | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
melanoma
n1=en:sebaceous epithelioma | n2=melanoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
mélanome
n1=en:sebaceous epithelioma | n2=mélanome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
mélanome bénin juvénile
n1=en:sebaceous epithelioma | n2=mélanome bénin juvénile | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
méningiome angiomateux
n1=en:sebaceous epithelioma | n2=méningiome angiomateux | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
méningiomes
n1=en:sebaceous epithelioma | n2=méningiomes | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
Méningiomes
n1=en:sebaceous epithelioma | n2=Méningiomes | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
mésothéliome
n1=en:sebaceous epithelioma | n2=mésothéliome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
myélome plasmocytaire
n1=en:sebaceous epithelioma | n2=myélome plasmocytaire | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
myxoma
n1=en:sebaceous epithelioma | n2=myxoma | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
myxome
n1=en:sebaceous epithelioma | n2=myxome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
myxomes cardiaques et cutanés, lentiginose faciale et syndrome de Cushing
n1=en:sebaceous epithelioma | n2=myxomes cardiaques et cutanés, lentiginose faciale et syndrome de Cushing | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
naevus bleu
n1=en:sebaceous epithelioma | n2=naevus bleu | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
naevus de Spitz
n1=en:sebaceous epithelioma | n2=naevus de Spitz | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
naevus de spitz
n1=en:sebaceous epithelioma | n2=naevus de spitz | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
naevus mixte
n1=en:sebaceous epithelioma | n2=naevus mixte | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
nævus de Sutton
n1=en:sebaceous epithelioma | n2=nævus de Sutton | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
nævus mixte
n1=en:sebaceous epithelioma | n2=nævus mixte | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
neo
n1=en:sebaceous epithelioma | n2=neo | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
néoplasie du côlon
n1=en:sebaceous epithelioma | n2=néoplasie du côlon | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
néoplasme bénin
n1=en:sebaceous epithelioma | n2=néoplasme bénin | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
néoplasme malin non classé
n1=en:sebaceous epithelioma | n2=néoplasme malin non classé | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
neurilemmome
n1=en:sebaceous epithelioma | n2=neurilemmome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
neurinome
n1=en:sebaceous epithelioma | n2=neurinome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
neurinome acoustique
n1=en:sebaceous epithelioma | n2=neurinome acoustique | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
neurinome de l'acoustique
n1=en:sebaceous epithelioma | n2=neurinome de l'acoustique | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
Neurinome de l'acoustique
n1=en:sebaceous epithelioma | n2=Neurinome de l'acoustique | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
neurinome malin
n1=en:sebaceous epithelioma | n2=neurinome malin | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
névrome
n1=en:sebaceous epithelioma | n2=névrome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
névrome cutané
n1=en:sebaceous epithelioma | n2=névrome cutané | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
névrome palissadique encapsulé
n1=en:sebaceous epithelioma | n2=névrome palissadique encapsulé | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
névrome, sai
n1=en:sebaceous epithelioma | n2=névrome, sai | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
non précisée, tumeur maligne de l'oesophage
n1=en:sebaceous epithelioma | n2=non précisée, tumeur maligne de l'oesophage | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
oligodendrogliome
n1=en:sebaceous epithelioma | n2=oligodendrogliome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
ostéome cutané
n1=en:sebaceous epithelioma | n2=ostéome cutané | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
ostéosarcome
n1=en:sebaceous epithelioma | n2=ostéosarcome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
pancréas (cancer du)
n1=en:sebaceous epithelioma | n2=pancréas (cancer du) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
partie non précisée tumeur maligne du pancréas
n1=en:sebaceous epithelioma | n2=partie non précisée tumeur maligne du pancréas | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
poumon vert
n1=en:sebaceous epithelioma | n2=poumon vert | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
rétinoblastome
n1=en:sebaceous epithelioma | n2=rétinoblastome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
rhabdomyosarcome
n1=en:sebaceous epithelioma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
rhabdomyosarcomes
n1=en:sebaceous epithelioma | n2=rhabdomyosarcomes | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
sarcome
n1=en:sebaceous epithelioma | n2=sarcome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
schwannogliome
n1=en:sebaceous epithelioma | n2=schwannogliome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
schwannome
n1=en:sebaceous epithelioma | n2=schwannome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
schwannome ancien
n1=en:sebaceous epithelioma | n2=schwannome ancien | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
schwannome bénin
n1=en:sebaceous epithelioma | n2=schwannome bénin | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
schwannome cellulaire
n1=en:sebaceous epithelioma | n2=schwannome cellulaire | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
schwannome dégénéré
n1=en:sebaceous epithelioma | n2=schwannome dégénéré | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
schwannome malin
n1=en:sebaceous epithelioma | n2=schwannome malin | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
schwannome mélanocytaire
n1=en:sebaceous epithelioma | n2=schwannome mélanocytaire | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
schwannome pigmenté
n1=en:sebaceous epithelioma | n2=schwannome pigmenté | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
schwannome plexiforme
n1=en:sebaceous epithelioma | n2=schwannome plexiforme | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
schwannome psammomateux
n1=en:sebaceous epithelioma | n2=schwannome psammomateux | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
sébacéome
n1=en:sebaceous epithelioma | n2=sébacéome | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
skin tag
n1=en:sebaceous epithelioma | n2=skin tag | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
syringo-cystadénome papillifère
n1=en:sebaceous epithelioma | n2=syringo-cystadénome papillifère | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
syringocystadénome papillaire
n1=en:sebaceous epithelioma | n2=syringocystadénome papillaire | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
syringocystadénome papillifère
n1=en:sebaceous epithelioma | n2=syringocystadénome papillifère | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
Tièche-Jadassohn (nævus de)
n1=en:sebaceous epithelioma | n2=Tièche-Jadassohn (nævus de) | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
Tumeur bénigne
n1=en:sebaceous epithelioma | n2=Tumeur bénigne | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur bénigne
n1=en:sebaceous epithelioma | n2=tumeur bénigne | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur colique
n1=en:sebaceous epithelioma | n2=tumeur colique | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur colo-rectale
n1=en:sebaceous epithelioma | n2=tumeur colo-rectale | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur colorectale
n1=en:sebaceous epithelioma | n2=tumeur colorectale | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur cutanée maligne
n1=en:sebaceous epithelioma | n2=tumeur cutanée maligne | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur d'autres sièges précisés à évolution imprévisible ou inconnue
n1=en:sebaceous epithelioma | n2=tumeur d'autres sièges précisés à évolution imprévisible ou inconnue | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur d'autres sites non précisés à évolution imprévisible
n1=en:sebaceous epithelioma | n2=tumeur d'autres sites non précisés à évolution imprévisible | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur d'autres sites précisés à évolution imprévisible ou inconnue
n1=en:sebaceous epithelioma | n2=tumeur d'autres sites précisés à évolution imprévisible ou inconnue | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur de bénignité ou de malignité non assurée
n1=en:sebaceous epithelioma | n2=tumeur de bénignité ou de malignité non assurée | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur de Grawitz
n1=en:sebaceous epithelioma | n2=tumeur de Grawitz | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur de l'oeil
n1=en:sebaceous epithelioma | n2=tumeur de l'oeil | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur du côlon
n1=en:sebaceous epithelioma | n2=tumeur du côlon | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur du pancréas
n1=en:sebaceous epithelioma | n2=tumeur du pancréas | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur maligne de gaine nerveuse périphérique
n1=en:sebaceous epithelioma | n2=tumeur maligne de gaine nerveuse périphérique | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur maligne de l'oesophage
n1=en:sebaceous epithelioma | n2=tumeur maligne de l'oesophage | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur maligne de la peau
n1=en:sebaceous epithelioma | n2=tumeur maligne de la peau | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur maligne de siège non précisé
n1=en:sebaceous epithelioma | n2=tumeur maligne de siège non précisé | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur maligne de siège primitif inconnu
n1=en:sebaceous epithelioma | n2=tumeur maligne de siège primitif inconnu | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur maligne du duodénum
n1=en:sebaceous epithelioma | n2=tumeur maligne du duodénum | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur maligne du pancréas
n1=en:sebaceous epithelioma | n2=tumeur maligne du pancréas | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur maligne non classée
n1=en:sebaceous epithelioma | n2=tumeur maligne non classée | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur maligne oesophagienne
n1=en:sebaceous epithelioma | n2=tumeur maligne oesophagienne | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur maligne pancréatique
n1=en:sebaceous epithelioma | n2=tumeur maligne pancréatique | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur maligne sans précision de site
n1=en:sebaceous epithelioma | n2=tumeur maligne sans précision de site | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur non classée de bénignité ou de malignité incertaine
n1=en:sebaceous epithelioma | n2=tumeur non classée de bénignité ou de malignité incertaine | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur pancréatique maligne
n1=en:sebaceous epithelioma | n2=tumeur pancréatique maligne | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur tubulopapillaire du rein
n1=en:sebaceous epithelioma | n2=tumeur tubulopapillaire du rein | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeur vasculaire
n1=en:sebaceous epithelioma | n2=tumeur vasculaire | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeurs du pancréas
n1=en:sebaceous epithelioma | n2=tumeurs du pancréas | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeurs du pancreas
n1=en:sebaceous epithelioma | n2=tumeurs du pancreas | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeurs hématopoïétiques
n1=en:sebaceous epithelioma | n2=tumeurs hématopoïétiques | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma --
r_associated #0: 20 / 0.488 ->
tumeurs pancréatiques
n1=en:sebaceous epithelioma | n2=tumeurs pancréatiques | rel=r_associated | relid=0 | w=20
| ≈ 719 relations entrantes
- carcinome de l'endomètre ---
r_associated #0: 472 -->
en:sebaceous epithelioma
n1=carcinome de l'endomètre | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=472
- en:endometrial carcinoma ---
r_associated #0: 468 -->
en:sebaceous epithelioma
n1=en:endometrial carcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=468
- lam ---
r_associated #0: 391 -->
en:sebaceous epithelioma
n1=lam | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=391
- la à granulocytes ---
r_associated #0: 390 -->
en:sebaceous epithelioma
n1=la à granulocytes | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=390
- leucémie aiguë myélocytaire ---
r_associated #0: 390 -->
en:sebaceous epithelioma
n1=leucémie aiguë myélocytaire | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=390
- leucémie aiguë non lymphoblastique ---
r_associated #0: 390 -->
en:sebaceous epithelioma
n1=leucémie aiguë non lymphoblastique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=390
- leucémie aiguë non lymphocytaire ---
r_associated #0: 390 -->
en:sebaceous epithelioma
n1=leucémie aiguë non lymphocytaire | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=390
- leucémie aigüe myéloblastique ---
r_associated #0: 390 -->
en:sebaceous epithelioma
n1=leucémie aigüe myéloblastique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=390
- leucémie granuleuse aiguë ---
r_associated #0: 390 -->
en:sebaceous epithelioma
n1=leucémie granuleuse aiguë | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=390
- leucémie granulocytaire aiguë ---
r_associated #0: 390 -->
en:sebaceous epithelioma
n1=leucémie granulocytaire aiguë | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=390
- leucémie non lymphoblastique aiguë ---
r_associated #0: 390 -->
en:sebaceous epithelioma
n1=leucémie non lymphoblastique aiguë | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=390
- en:acute myeloid leukemia ---
r_associated #0: 387 -->
en:sebaceous epithelioma
n1=en:acute myeloid leukemia | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=387
- lanl ---
r_associated #0: 380 -->
en:sebaceous epithelioma
n1=lanl | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=380
- leucémie myéloïde aiguë ---
r_associated #0: 380 -->
en:sebaceous epithelioma
n1=leucémie myéloïde aiguë | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=380
- leucémie myélogène aiguë ---
r_associated #0: 370 -->
en:sebaceous epithelioma
n1=leucémie myélogène aiguë | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=370
- leucémie aigüe non lymphoblastique ---
r_associated #0: 360 -->
en:sebaceous epithelioma
n1=leucémie aigüe non lymphoblastique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=360
- leucémie myéloblastique aiguë ---
r_associated #0: 360 -->
en:sebaceous epithelioma
n1=leucémie myéloblastique aiguë | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=360
- leucémie myélogène aigüe ---
r_associated #0: 360 -->
en:sebaceous epithelioma
n1=leucémie myélogène aigüe | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=360
- en:malignant neoplasm ---
r_associated #0: 359 -->
en:sebaceous epithelioma
n1=en:malignant neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=359
- néoplasme malin ---
r_associated #0: 359 -->
en:sebaceous epithelioma
n1=néoplasme malin | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=359
- leucémie blastique granulocytaire ---
r_associated #0: 355 -->
en:sebaceous epithelioma
n1=leucémie blastique granulocytaire | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=355
- maladie néoplasique maligne ---
r_associated #0: 355 -->
en:sebaceous epithelioma
n1=maladie néoplasique maligne | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=355
- tumeur maligne de siège primitif inconnu ---
r_associated #0: 340 -->
en:sebaceous epithelioma
n1=tumeur maligne de siège primitif inconnu | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=340
- tumeur maligne sans précision de site ---
r_associated #0: 340 -->
en:sebaceous epithelioma
n1=tumeur maligne sans précision de site | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=340
- leucémie aiguë granulocytaire ---
r_associated #0: 335 -->
en:sebaceous epithelioma
n1=leucémie aiguë granulocytaire | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=335
- leucémie aigüe myéloïde ---
r_associated #0: 335 -->
en:sebaceous epithelioma
n1=leucémie aigüe myéloïde | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=335
- leucémie myélocytaire aiguë ---
r_associated #0: 335 -->
en:sebaceous epithelioma
n1=leucémie myélocytaire aiguë | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=335
- leucémie myéloïde aigüe ---
r_associated #0: 335 -->
en:sebaceous epithelioma
n1=leucémie myéloïde aigüe | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=335
- néoplasme malin non classé ---
r_associated #0: 330 -->
en:sebaceous epithelioma
n1=néoplasme malin non classé | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=330
- cancer pancréatique ---
r_associated #0: 325 -->
en:sebaceous epithelioma
n1=cancer pancréatique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=325
- carcinome du pancreas ---
r_associated #0: 322 -->
en:sebaceous epithelioma
n1=carcinome du pancreas | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=322
- carcinome pancréatique ---
r_associated #0: 322 -->
en:sebaceous epithelioma
n1=carcinome pancréatique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=322
- leucémies myéloïdes aiguës ---
r_associated #0: 320 -->
en:sebaceous epithelioma
n1=leucémies myéloïdes aiguës | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=320
- tumeur maligne non classée ---
r_associated #0: 320 -->
en:sebaceous epithelioma
n1=tumeur maligne non classée | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=320
- tumeur maligne pancréatique ---
r_associated #0: 320 -->
en:sebaceous epithelioma
n1=tumeur maligne pancréatique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=320
- en:pancreatic carcinoma ---
r_associated #0: 318 -->
en:sebaceous epithelioma
n1=en:pancreatic carcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=318
- leucémie aiguë myéloïde ---
r_associated #0: 315 -->
en:sebaceous epithelioma
n1=leucémie aiguë myéloïde | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=315
- partie non précisée tumeur maligne du pancréas ---
r_associated #0: 315 -->
en:sebaceous epithelioma
n1=partie non précisée tumeur maligne du pancréas | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=315
- carcinome du pancréas ---
r_associated #0: 314 -->
en:sebaceous epithelioma
n1=carcinome du pancréas | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=314
- méningiome ---
r_associated #0: 313 -->
en:sebaceous epithelioma
n1=méningiome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=313
- en:meningioma ---
r_associated #0: 310 -->
en:sebaceous epithelioma
n1=en:meningioma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=310
- en:schwannoma ---
r_associated #0: 310 -->
en:sebaceous epithelioma
n1=en:schwannoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=310
- schwannogliome ---
r_associated #0: 310 -->
en:sebaceous epithelioma
n1=schwannogliome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=310
- schwannome ---
r_associated #0: 309 -->
en:sebaceous epithelioma
n1=schwannome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=309
- leucémie aiguë myéloblastique ---
r_associated #0: 305 -->
en:sebaceous epithelioma
n1=leucémie aiguë myéloblastique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=305
- leucémie myéloblastique aigüe ---
r_associated #0: 305 -->
en:sebaceous epithelioma
n1=leucémie myéloblastique aigüe | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=305
- neurinome ---
r_associated #0: 305 -->
en:sebaceous epithelioma
n1=neurinome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=305
- schwannome bénin ---
r_associated #0: 302 -->
en:sebaceous epithelioma
n1=schwannome bénin | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=302
- gliome périphérique ---
r_associated #0: 300 -->
en:sebaceous epithelioma
n1=gliome périphérique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=300
- lemmome ---
r_associated #0: 300 -->
en:sebaceous epithelioma
n1=lemmome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=300
- schwannome cellulaire ---
r_associated #0: 300 -->
en:sebaceous epithelioma
n1=schwannome cellulaire | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=300
- schwannome mélanocytaire ---
r_associated #0: 300 -->
en:sebaceous epithelioma
n1=schwannome mélanocytaire | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=300
- tumeur pancréatique maligne ---
r_associated #0: 300 -->
en:sebaceous epithelioma
n1=tumeur pancréatique maligne | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=300
- tumeurs du pancreas ---
r_associated #0: 290 -->
en:sebaceous epithelioma
n1=tumeurs du pancreas | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=290
- schwannome dégénéré ---
r_associated #0: 285 -->
en:sebaceous epithelioma
n1=schwannome dégénéré | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=285
- schwannome psammomateux ---
r_associated #0: 285 -->
en:sebaceous epithelioma
n1=schwannome psammomateux | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=285
- tumeur maligne du pancréas ---
r_associated #0: 280 -->
en:sebaceous epithelioma
n1=tumeur maligne du pancréas | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=280
- tumeurs pancréatiques ---
r_associated #0: 279 -->
en:sebaceous epithelioma
n1=tumeurs pancréatiques | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=279
- cancer du pancréas ---
r_associated #0: 276 -->
en:sebaceous epithelioma
n1=cancer du pancréas | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=276
- névrome palissadique encapsulé ---
r_associated #0: 276 -->
en:sebaceous epithelioma
n1=névrome palissadique encapsulé | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=276
- schwannome plexiforme ---
r_associated #0: 275 -->
en:sebaceous epithelioma
n1=schwannome plexiforme | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=275
- tumeur du pancréas ---
r_associated #0: 275 -->
en:sebaceous epithelioma
n1=tumeur du pancréas | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=275
- névrome ---
r_associated #0: 265 -->
en:sebaceous epithelioma
n1=névrome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=265
- schwannome pigmenté ---
r_associated #0: 265 -->
en:sebaceous epithelioma
n1=schwannome pigmenté | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=265
- neurinome acoustique ---
r_associated #0: 260 -->
en:sebaceous epithelioma
n1=neurinome acoustique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=260
- neurinome de l'acoustique ---
r_associated #0: 260 -->
en:sebaceous epithelioma
n1=neurinome de l'acoustique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=260
- tumeur maligne de gaine nerveuse périphérique ---
r_associated #0: 260 -->
en:sebaceous epithelioma
n1=tumeur maligne de gaine nerveuse périphérique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=260
- tumeurs du pancréas ---
r_associated #0: 260 -->
en:sebaceous epithelioma
n1=tumeurs du pancréas | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=260
- en:neuroma ---
r_associated #0: 256 -->
en:sebaceous epithelioma
n1=en:neuroma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=256
- neurinome malin ---
r_associated #0: 256 -->
en:sebaceous epithelioma
n1=neurinome malin | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=256
- schwannome malin ---
r_associated #0: 256 -->
en:sebaceous epithelioma
n1=schwannome malin | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=256
- névrome, sai ---
r_associated #0: 255 -->
en:sebaceous epithelioma
n1=névrome, sai | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=255
- schwannome ancien ---
r_associated #0: 255 -->
en:sebaceous epithelioma
n1=schwannome ancien | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=255
- neurilemmome ---
r_associated #0: 254 -->
en:sebaceous epithelioma
n1=neurilemmome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=254
- méningiomes ---
r_associated #0: 243 -->
en:sebaceous epithelioma
n1=méningiomes | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=243
- en:angiomatous meningioma ---
r_associated #0: 240 -->
en:sebaceous epithelioma
n1=en:angiomatous meningioma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=240
- en:sarcoma ---
r_associated #0: 227 -->
en:sebaceous epithelioma
n1=en:sarcoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=227
- méningiome angiomateux ---
r_associated #0: 226 -->
en:sebaceous epithelioma
n1=méningiome angiomateux | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=226
- carcinome glandulaire ---
r_associated #0: 225 -->
en:sebaceous epithelioma
n1=carcinome glandulaire | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=225
- sarcome ---
r_associated #0: 223 -->
en:sebaceous epithelioma
n1=sarcome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=223
- en:adenocarcinoma ---
r_associated #0: 221 -->
en:sebaceous epithelioma
n1=en:adenocarcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=221
- adénocarcinome ---
r_associated #0: 220 -->
en:sebaceous epithelioma
n1=adénocarcinome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=220
- hémangiome ---
r_associated #0: 198 -->
en:sebaceous epithelioma
n1=hémangiome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=198
- en:blood vessel neoplasm ---
r_associated #0: 197 -->
en:sebaceous epithelioma
n1=en:blood vessel neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=197
- en:hemangioma ---
r_associated #0: 186 -->
en:sebaceous epithelioma
n1=en:hemangioma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=186
- leucémie ---
r_associated #0: 181 -->
en:sebaceous epithelioma
n1=leucémie | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=181
- cancer endométrial ---
r_associated #0: 180 -->
en:sebaceous epithelioma
n1=cancer endométrial | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=180
- en:leukemia ---
r_associated #0: 180 -->
en:sebaceous epithelioma
n1=en:leukemia | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=180
- carcinome endométrial ---
r_associated #0: 177 -->
en:sebaceous epithelioma
n1=carcinome endométrial | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=177
- en:neoplasm, uncertain whether benign or malignant ---
r_associated #0: 177 -->
en:sebaceous epithelioma
n1=en:neoplasm, uncertain whether benign or malignant | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=177
- rhabdomyosarcome ---
r_associated #0: 175 -->
en:sebaceous epithelioma
n1=rhabdomyosarcome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=175
- tumeur non classée de bénignité ou de malignité incertaine ---
r_associated #0: 175 -->
en:sebaceous epithelioma
n1=tumeur non classée de bénignité ou de malignité incertaine | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=175
- en:rhabdomyosarcoma ---
r_associated #0: 174 -->
en:sebaceous epithelioma
n1=en:rhabdomyosarcoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=174
- adénome malin ---
r_associated #0: 170 -->
en:sebaceous epithelioma
n1=adénome malin | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=170
- en:pancreatic neoplasm ---
r_associated #0: 168 -->
en:sebaceous epithelioma
n1=en:pancreatic neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=168
- en:malignant pancreatic neoplasm ---
r_associated #0: 167 -->
en:sebaceous epithelioma
n1=en:malignant pancreatic neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=167
- adénome à cellules oncocytaires ---
r_associated #0: 166 -->
en:sebaceous epithelioma
n1=adénome à cellules oncocytaires | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=166
- Adénocarcinome ---
r_associated #0: 165 -->
en:sebaceous epithelioma
n1=Adénocarcinome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=165
- cancer de l'endomètre ---
r_associated #0: 165 -->
en:sebaceous epithelioma
n1=cancer de l'endomètre | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=165
- cellule tumorale ---
r_associated #0: 160 -->
en:sebaceous epithelioma
n1=cellule tumorale | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=160
- en:neoplastic cell ---
r_associated #0: 159 -->
en:sebaceous epithelioma
n1=en:neoplastic cell | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=159
- en:oncocytic adenoma ---
r_associated #0: 158 -->
en:sebaceous epithelioma
n1=en:oncocytic adenoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=158
- adénome oncocytaire ---
r_associated #0: 155 -->
en:sebaceous epithelioma
n1=adénome oncocytaire | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=155
- neo ---
r_associated #0: 150 -->
en:sebaceous epithelioma
n1=neo | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=150
- cancers ---
r_associated #0: 145 -->
en:sebaceous epithelioma
n1=cancers | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=145
- tumeur vasculaire ---
r_associated #0: 145 -->
en:sebaceous epithelioma
n1=tumeur vasculaire | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=145
- rétinoblastome ---
r_associated #0: 138 -->
en:sebaceous epithelioma
n1=rétinoblastome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=138
- en:retinoblastoma ---
r_associated #0: 136 -->
en:sebaceous epithelioma
n1=en:retinoblastoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=136
- en:haematopoietic neoplasms (excl leukaemias and lymphomas) ---
r_associated #0: 135 -->
en:sebaceous epithelioma
n1=en:haematopoietic neoplasms (excl leukaemias and lymphomas) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=135
- tumeurs hématopoïétiques ---
r_associated #0: 131 -->
en:sebaceous epithelioma
n1=tumeurs hématopoïétiques | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=131
- rhabdomyosarcomes ---
r_associated #0: 125 -->
en:sebaceous epithelioma
n1=rhabdomyosarcomes | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=125
- en:colon adenocarcinoma ---
r_associated #0: 121 -->
en:sebaceous epithelioma
n1=en:colon adenocarcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=121
- adenocarcinoma ---
r_associated #0: 120 -->
en:sebaceous epithelioma
n1=adenocarcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=120
- tumeur maligne de la peau ---
r_associated #0: 120 -->
en:sebaceous epithelioma
n1=tumeur maligne de la peau | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=120
- en:adenocarcinoma of colon ---
r_associated #0: 118 -->
en:sebaceous epithelioma
n1=en:adenocarcinoma of colon | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=118
- en:malignant skin neoplasm ---
r_associated #0: 118 -->
en:sebaceous epithelioma
n1=en:malignant skin neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=118
- adénocarcinome du côlon ---
r_associated #0: 116 -->
en:sebaceous epithelioma
n1=adénocarcinome du côlon | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=116
- cancer cutané ---
r_associated #0: 115 -->
en:sebaceous epithelioma
n1=cancer cutané | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=115
- en:malignant neoplasm of skin ---
r_associated #0: 115 -->
en:sebaceous epithelioma
n1=en:malignant neoplasm of skin | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=115
- cancer de la peau ---
r_associated #0: 110 -->
en:sebaceous epithelioma
n1=cancer de la peau | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=110
- en:malignant esophageal neoplasm ---
r_associated #0: 108 -->
en:sebaceous epithelioma
n1=en:malignant esophageal neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=108
- tumeur de bénignité ou de malignité non assurée ---
r_associated #0: 105 -->
en:sebaceous epithelioma
n1=tumeur de bénignité ou de malignité non assurée | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=105
- tumeur maligne oesophagienne ---
r_associated #0: 105 -->
en:sebaceous epithelioma
n1=tumeur maligne oesophagienne | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=105
- en:leukaemia ---
r_associated #0: 100 -->
en:sebaceous epithelioma
n1=en:leukaemia | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=100
- tumeur cutanée maligne ---
r_associated #0: 100 -->
en:sebaceous epithelioma
n1=tumeur cutanée maligne | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=100
- tumeur d'autres sites précisés à évolution imprévisible ou inconnue ---
r_associated #0: 100 -->
en:sebaceous epithelioma
n1=tumeur d'autres sites précisés à évolution imprévisible ou inconnue | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=100
- cancer de l'oesophage ---
r_associated #0: 96 -->
en:sebaceous epithelioma
n1=cancer de l'oesophage | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=96
- cancer de l'œsophage ---
r_associated #0: 95 -->
en:sebaceous epithelioma
n1=cancer de l'œsophage | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=95
- poumon vert ---
r_associated #0: 95 -->
en:sebaceous epithelioma
n1=poumon vert | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=95
- syringocystadénome papillaire ---
r_associated #0: 95 -->
en:sebaceous epithelioma
n1=syringocystadénome papillaire | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=95
- tumeur d'autres sièges précisés à évolution imprévisible ou inconnue ---
r_associated #0: 95 -->
en:sebaceous epithelioma
n1=tumeur d'autres sièges précisés à évolution imprévisible ou inconnue | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=95
- en:lung ---
r_associated #0: 92 -->
en:sebaceous epithelioma
n1=en:lung | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=92
- en:neoplasm of uncertain behavior of other specified sites ---
r_associated #0: 91 -->
en:sebaceous epithelioma
n1=en:neoplasm of uncertain behavior of other specified sites | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=91
- syringocystadénome papillifère ---
r_associated #0: 91 -->
en:sebaceous epithelioma
n1=syringocystadénome papillifère | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=91
- tumeur maligne de l'oesophage ---
r_associated #0: 91 -->
en:sebaceous epithelioma
n1=tumeur maligne de l'oesophage | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=91
- LA à granulocytes ---
r_associated #0: 90 -->
en:sebaceous epithelioma
n1=LA à granulocytes | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=90
- cancer de l'œsophage ---
r_associated #0: 90 -->
en:sebaceous epithelioma
n1=cancer de l'œsophage | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=90
- cancer du sang ---
r_associated #0: 90 -->
en:sebaceous epithelioma
n1=cancer du sang | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=90
- en:acute myeloblastic leukaemia ---
r_associated #0: 90 -->
en:sebaceous epithelioma
n1=en:acute myeloblastic leukaemia | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=90
- en:endometrial cancer ---
r_associated #0: 90 -->
en:sebaceous epithelioma
n1=en:endometrial cancer | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=90
- lipome ---
r_associated #0: 90 -->
en:sebaceous epithelioma
n1=lipome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=90
- lung ---
r_associated #0: 90 -->
en:sebaceous epithelioma
n1=lung | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=90
- en:syringocystadenoma papilliferum ---
r_associated #0: 89 -->
en:sebaceous epithelioma
n1=en:syringocystadenoma papilliferum | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=89
- en:lipoma ---
r_associated #0: 87 -->
en:sebaceous epithelioma
n1=en:lipoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=87
- tumeur maligne de siège non précisé ---
r_associated #0: 87 -->
en:sebaceous epithelioma
n1=tumeur maligne de siège non précisé | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=87
- en:pancreatic cancer ---
r_associated #0: 86 -->
en:sebaceous epithelioma
n1=en:pancreatic cancer | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=86
- tumeur d'autres sites non précisés à évolution imprévisible ---
r_associated #0: 85 -->
en:sebaceous epithelioma
n1=tumeur d'autres sites non précisés à évolution imprévisible | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=85
- en:tumor cell ---
r_associated #0: 77 -->
en:sebaceous epithelioma
n1=en:tumor cell | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=77
- cancer glandulaire ---
r_associated #0: 76 -->
en:sebaceous epithelioma
n1=cancer glandulaire | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=76
- en:benign fibrous histiocytoma ---
r_associated #0: 75 -->
en:sebaceous epithelioma
n1=en:benign fibrous histiocytoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=75
- en:histiocytoma, benign fibrous ---
r_associated #0: 75 -->
en:sebaceous epithelioma
n1=en:histiocytoma, benign fibrous | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=75
- histiocytofibrome bénin ---
r_associated #0: 75 -->
en:sebaceous epithelioma
n1=histiocytofibrome bénin | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=75
- tumeur colique ---
r_associated #0: 75 -->
en:sebaceous epithelioma
n1=tumeur colique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=75
- histiocytome fibreux bénin ---
r_associated #0: 71 -->
en:sebaceous epithelioma
n1=histiocytome fibreux bénin | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=71
- mélanome bénin juvénile ---
r_associated #0: 70 -->
en:sebaceous epithelioma
n1=mélanome bénin juvénile | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=70
- en:spitz nevus ---
r_associated #0: 69 -->
en:sebaceous epithelioma
n1=en:spitz nevus | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=69
- naevus de Spitz ---
r_associated #0: 69 -->
en:sebaceous epithelioma
n1=naevus de Spitz | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=69
- en:colon neoplasm ---
r_associated #0: 68 -->
en:sebaceous epithelioma
n1=en:colon neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=68
- cancer colo-rectal ---
r_associated #0: 66 -->
en:sebaceous epithelioma
n1=cancer colo-rectal | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=66
- Cancer de la peau ---
r_associated #0: 65 -->
en:sebaceous epithelioma
n1=Cancer de la peau | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=65
- carcinome colo-rectal ---
r_associated #0: 65 -->
en:sebaceous epithelioma
n1=carcinome colo-rectal | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=65
- carcinome colorectal ---
r_associated #0: 65 -->
en:sebaceous epithelioma
n1=carcinome colorectal | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=65
- carcinome recto-colique ---
r_associated #0: 65 -->
en:sebaceous epithelioma
n1=carcinome recto-colique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=65
- carcinome rectocolique ---
r_associated #0: 65 -->
en:sebaceous epithelioma
n1=carcinome rectocolique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=65
- en:acute myeloblastic leukemia ---
r_associated #0: 65 -->
en:sebaceous epithelioma
n1=en:acute myeloblastic leukemia | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=65
- en:leukocythemia ---
r_associated #0: 65 -->
en:sebaceous epithelioma
n1=en:leukocythemia | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=65
- tumeur colo-rectale ---
r_associated #0: 65 -->
en:sebaceous epithelioma
n1=tumeur colo-rectale | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=65
- tumeur colorectale ---
r_associated #0: 65 -->
en:sebaceous epithelioma
n1=tumeur colorectale | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=65
- dermatofibrome ---
r_associated #0: 64 -->
en:sebaceous epithelioma
n1=dermatofibrome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=64
- tumeur de l'oeil ---
r_associated #0: 63 -->
en:sebaceous epithelioma
n1=tumeur de l'oeil | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=63
- cancer colorectal ---
r_associated #0: 61 -->
en:sebaceous epithelioma
n1=cancer colorectal | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=61
- en:colonic neoplasms ---
r_associated #0: 61 -->
en:sebaceous epithelioma
n1=en:colonic neoplasms | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=61
- en:leucemia ---
r_associated #0: 61 -->
en:sebaceous epithelioma
n1=en:leucemia | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=61
- en:skin tag ---
r_associated #0: 61 -->
en:sebaceous epithelioma
n1=en:skin tag | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=61
- non précisée, tumeur maligne du côlon ---
r_associated #0: 60 -->
en:sebaceous epithelioma
n1=non précisée, tumeur maligne du côlon | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=60
- néoplasie du côlon ---
r_associated #0: 60 -->
en:sebaceous epithelioma
n1=néoplasie du côlon | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=60
- en:malignant colon neoplasm ---
r_associated #0: 59 -->
en:sebaceous epithelioma
n1=en:malignant colon neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=59
- skin tag ---
r_associated #0: 58 -->
en:sebaceous epithelioma
n1=skin tag | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=58
- tumeur maligne colique ---
r_associated #0: 58 -->
en:sebaceous epithelioma
n1=tumeur maligne colique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=58
- cancer colique ---
r_associated #0: 56 -->
en:sebaceous epithelioma
n1=cancer colique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=56
- cancer du duodénum ---
r_associated #0: 56 -->
en:sebaceous epithelioma
n1=cancer du duodénum | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=56
- cancer oesophagien ---
r_associated #0: 55 -->
en:sebaceous epithelioma
n1=cancer oesophagien | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=55
- en:malignant tumor of colon ---
r_associated #0: 55 -->
en:sebaceous epithelioma
n1=en:malignant tumor of colon | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=55
- en:skin cancer ---
r_associated #0: 55 -->
en:sebaceous epithelioma
n1=en:skin cancer | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=55
- cancer duodénal ---
r_associated #0: 52 -->
en:sebaceous epithelioma
n1=cancer duodénal | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=52
- fibrome molluscum ---
r_associated #0: 52 -->
en:sebaceous epithelioma
n1=fibrome molluscum | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=52
- tumeur du côlon ---
r_associated #0: 52 -->
en:sebaceous epithelioma
n1=tumeur du côlon | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=52
- Neurinome de l'acoustique ---
r_associated #0: 50 -->
en:sebaceous epithelioma
n1=Neurinome de l'acoustique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=50
- carcinome duodénal ---
r_associated #0: 50 -->
en:sebaceous epithelioma
n1=carcinome duodénal | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=50
- dysgerminome ---
r_associated #0: 50 -->
en:sebaceous epithelioma
n1=dysgerminome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=50
- en:neurinoma ---
r_associated #0: 50 -->
en:sebaceous epithelioma
n1=en:neurinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=50
- en:cutaneous fibrous polyp ---
r_associated #0: 49 -->
en:sebaceous epithelioma
n1=en:cutaneous fibrous polyp | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=49
- en:duodenal cancer ---
r_associated #0: 49 -->
en:sebaceous epithelioma
n1=en:duodenal cancer | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=49
- en:dysgerminoma ---
r_associated #0: 49 -->
en:sebaceous epithelioma
n1=en:dysgerminoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=49
- tumeur maligne duodénale ---
r_associated #0: 48 -->
en:sebaceous epithelioma
n1=tumeur maligne duodénale | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=48
- carcinome du gros intestin ---
r_associated #0: 47 -->
en:sebaceous epithelioma
n1=carcinome du gros intestin | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=47
- syringo-cystadénome papillifère ---
r_associated #0: 46 -->
en:sebaceous epithelioma
n1=syringo-cystadénome papillifère | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=46
- en:benign growth ---
r_associated #0: 45 -->
en:sebaceous epithelioma
n1=en:benign growth | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=45
- en:benign neoplasm ---
r_associated #0: 45 -->
en:sebaceous epithelioma
n1=en:benign neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=45
- en:benign tumour ---
r_associated #0: 45 -->
en:sebaceous epithelioma
n1=en:benign tumour | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=45
- tumeur bénigne ---
r_associated #0: 45 -->
en:sebaceous epithelioma
n1=tumeur bénigne | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=45
- fibrosarcome ---
r_associated #0: 44 -->
en:sebaceous epithelioma
n1=fibrosarcome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=44
- en:benign hair follicle neoplasm ---
r_associated #0: 43 -->
en:sebaceous epithelioma
n1=en:benign hair follicle neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=43
- en:increased risk of myelodysplastic syndromes ---
r_associated #0: 43 -->
en:sebaceous epithelioma
n1=en:increased risk of myelodysplastic syndromes | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=43
- en:innocent tumor ---
r_associated #0: 43 -->
en:sebaceous epithelioma
n1=en:innocent tumor | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=43
- en:parotid oncocytomas ---
r_associated #0: 43 -->
en:sebaceous epithelioma
n1=en:parotid oncocytomas | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=43
- en:pyogenic granuloma of skin ---
r_associated #0: 43 -->
en:sebaceous epithelioma
n1=en:pyogenic granuloma of skin | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=43
- en:tumors at multiple other sites including cns ---
r_associated #0: 43 -->
en:sebaceous epithelioma
n1=en:tumors at multiple other sites including cns | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=43
- tumeur maligne du duodénum ---
r_associated #0: 43 -->
en:sebaceous epithelioma
n1=tumeur maligne du duodénum | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=43
- Cancer du pancréas ---
r_associated #0: 42 -->
en:sebaceous epithelioma
n1=Cancer du pancréas | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=42
- acrochordon ---
r_associated #0: 42 -->
en:sebaceous epithelioma
n1=acrochordon | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=42
- en:acute monocytic leukemia ---
r_associated #0: 42 -->
en:sebaceous epithelioma
n1=en:acute monocytic leukemia | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=42
- en:breast cancer, early-onset (in some patients) ---
r_associated #0: 42 -->
en:sebaceous epithelioma
n1=en:breast cancer, early-onset (in some patients) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=42
- en:increased risk for multiple myeloma ---
r_associated #0: 42 -->
en:sebaceous epithelioma
n1=en:increased risk for multiple myeloma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=42
- myxome ---
r_associated #0: 42 -->
en:sebaceous epithelioma
n1=myxome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=42
- poumon ---
r_associated #0: 42 -->
en:sebaceous epithelioma
n1=poumon | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=42
- tumeur tubulopapillaire du rein ---
r_associated #0: 42 -->
en:sebaceous epithelioma
n1=tumeur tubulopapillaire du rein | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=42
- en:benign neoplasm of skin of ear and external auditory meatus ---
r_associated #0: 41 -->
en:sebaceous epithelioma
n1=en:benign neoplasm of skin of ear and external auditory meatus | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=41
- en:increased susceptibility to juvenile myelomonocytic leukemia ---
r_associated #0: 41 -->
en:sebaceous epithelioma
n1=en:increased susceptibility to juvenile myelomonocytic leukemia | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=41
- Tièche-Jadassohn (nævus de) ---
r_associated #0: 40 -->
en:sebaceous epithelioma
n1=Tièche-Jadassohn (nævus de) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=40
- Tumeur bénigne ---
r_associated #0: 40 -->
en:sebaceous epithelioma
n1=Tumeur bénigne | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=40
- cancer de l'oeil ---
r_associated #0: 40 -->
en:sebaceous epithelioma
n1=cancer de l'oeil | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=40
- en:Tièche-Jadassohn's nevus ---
r_associated #0: 40 -->
en:sebaceous epithelioma
n1=en:Tièche-Jadassohn's nevus | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=40
- en:fibrosarcoma ---
r_associated #0: 40 -->
en:sebaceous epithelioma
n1=en:fibrosarcoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=40
- en:male germ cell tumors (gct), 2 subtypes - ---
r_associated #0: 40 -->
en:sebaceous epithelioma
n1=en:male germ cell tumors (gct), 2 subtypes - | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=40
- en:malignant central nervous system neoplasm ---
r_associated #0: 40 -->
en:sebaceous epithelioma
n1=en:malignant central nervous system neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=40
- en:malignant eye neoplasm ---
r_associated #0: 40 -->
en:sebaceous epithelioma
n1=en:malignant eye neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=40
- en:myxoma ---
r_associated #0: 40 -->
en:sebaceous epithelioma
n1=en:myxoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=40
- en:pancreas cancer ---
r_associated #0: 40 -->
en:sebaceous epithelioma
n1=en:pancreas cancer | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=40
- en:skin basal cell carcinoma with sebaceous differentiation ---
r_associated #0: 40 -->
en:sebaceous epithelioma
n1=en:skin basal cell carcinoma with sebaceous differentiation | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=40
- en:thyroid follicular cell tumor ---
r_associated #0: 40 -->
en:sebaceous epithelioma
n1=en:thyroid follicular cell tumor | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=40
- myélome plasmocytaire ---
r_associated #0: 40 -->
en:sebaceous epithelioma
n1=myélome plasmocytaire | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=40
- néoplasme bénin ---
r_associated #0: 40 -->
en:sebaceous epithelioma
n1=néoplasme bénin | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=40
- tumeur maligne de l'oeil ---
r_associated #0: 40 -->
en:sebaceous epithelioma
n1=tumeur maligne de l'oeil | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=40
- en:basocellular neoplasms ---
r_associated #0: 39 -->
en:sebaceous epithelioma
n1=en:basocellular neoplasms | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=39
- en:lymphatic vessel neoplasm ---
r_associated #0: 39 -->
en:sebaceous epithelioma
n1=en:lymphatic vessel neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=39
- en:melanoma ---
r_associated #0: 39 -->
en:sebaceous epithelioma
n1=en:melanoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=39
- en:papillary renal cell adenoma ---
r_associated #0: 39 -->
en:sebaceous epithelioma
n1=en:papillary renal cell adenoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=39
- mélanome ---
r_associated #0: 39 -->
en:sebaceous epithelioma
n1=mélanome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=39
- nævus mixte ---
r_associated #0: 39 -->
en:sebaceous epithelioma
n1=nævus mixte | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=39
- en:chordoma ---
r_associated #0: 38 -->
en:sebaceous epithelioma
n1=en:chordoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=38
- en:hematopoietic and lymphoid cell neoplasm ---
r_associated #0: 38 -->
en:sebaceous epithelioma
n1=en:hematopoietic and lymphoid cell neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=38
- en:blue nevus ---
r_associated #0: 37 -->
en:sebaceous epithelioma
n1=en:blue nevus | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=37
- myxomes cardiaques et cutanés, lentiginose faciale et syndrome de Cushing ---
r_associated #0: 37 -->
en:sebaceous epithelioma
n1=myxomes cardiaques et cutanés, lentiginose faciale et syndrome de Cushing | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=37
- cancer du côlon ---
r_associated #0: 36 -->
en:sebaceous epithelioma
n1=cancer du côlon | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=36
- en:colorectal carcinoma ---
r_associated #0: 36 -->
en:sebaceous epithelioma
n1=en:colorectal carcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=36
- en:neurilemmoma ---
r_associated #0: 36 -->
en:sebaceous epithelioma
n1=en:neurilemmoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=36
- en:papillary renal cell carcinoma ---
r_associated #0: 36 -->
en:sebaceous epithelioma
n1=en:papillary renal cell carcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=36
- en:plasma cell myeloma ---
r_associated #0: 36 -->
en:sebaceous epithelioma
n1=en:plasma cell myeloma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=36
- en:sweat gland neoplasm ---
r_associated #0: 36 -->
en:sebaceous epithelioma
n1=en:sweat gland neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=36
- lymphome folliculaire ---
r_associated #0: 36 -->
en:sebaceous epithelioma
n1=lymphome folliculaire | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=36
- melanoma ---
r_associated #0: 36 -->
en:sebaceous epithelioma
n1=melanoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=36
- oligodendrogliome ---
r_associated #0: 36 -->
en:sebaceous epithelioma
n1=oligodendrogliome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=36
- tumeur maligne du côlon ---
r_associated #0: 36 -->
en:sebaceous epithelioma
n1=tumeur maligne du côlon | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=36
- en:acinar cell neoplasm ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:acinar cell neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:adnexal and/or skin appendage neoplasm ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:adnexal and/or skin appendage neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:b-cell non-hodgkin lymphoma ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:b-cell non-hodgkin lymphoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:benign tumors of the eye, heart, and lungs ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:benign tumors of the eye, heart, and lungs | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:bone neoplasm ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:bone neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:carotid body tumors (most common location) ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:carotid body tumors (most common location) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:compound nevus ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:compound nevus | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:condyloma acuminatum ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:condyloma acuminatum | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:embryonal carcinoma ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:embryonal carcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:eye neoplasm ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:eye neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:fibrous skin tumor of tuberous sclerosis ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:fibrous skin tumor of tuberous sclerosis | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:gastrointestinal stromal tumors (less common) ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:gastrointestinal stromal tumors (less common) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:giant cell lesion of small bones ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:giant cell lesion of small bones | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:hepatocellular carcinoma, childhood onset (reported in 2 patients) ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:hepatocellular carcinoma, childhood onset (reported in 2 patients) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:in situ neoplasm (morphology) ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:in situ neoplasm (morphology) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:increased incidence of rectosigmoid cancer ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:increased incidence of rectosigmoid cancer | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:increased risk of hematologic malignancy (1 patient) ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:increased risk of hematologic malignancy (1 patient) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:increased risk of malignancy (classic feature) ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:increased risk of malignancy (classic feature) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:increased risk of tumor formation, especially of the head ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:increased risk of tumor formation, especially of the head | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:increased susceptibility to hematologic malignancies ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:increased susceptibility to hematologic malignancies | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:infected naevus ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:infected naevus | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:kidney wilms tumor ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:kidney wilms tumor | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:malignant cell ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:malignant cell | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:mesothelial neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:myelogeneous leukemia, chronic ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:myelogeneous leukemia, chronic | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:neoplasm of unspecified nature of respiratory system ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:neoplasm of unspecified nature of respiratory system | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:neoplasm related morbidities ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:neoplasm related morbidities | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:neoplasms, post-traumatic ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:neoplasms, post-traumatic | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:oligodendroglioma ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:oligodendroglioma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:optic glioma (19%) ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:optic glioma (19%) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:paraganglioma, catecholamine-secreting ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:paraganglioma, catecholamine-secreting | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:parotid gland monomorphic adenoma ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:parotid gland monomorphic adenoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:pheochromocytoma, extraadrenal (21%) ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:pheochromocytoma, extraadrenal (21%) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:precancerous condition ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:precancerous condition | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:sebaceous adenoma of skin ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:sebaceous adenoma of skin | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:sebaceous carcinoma ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:sebaceous carcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:skeletal neoplasms benign ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:skeletal neoplasms benign | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:skeletal neoplasms malignant and unspecified ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:skeletal neoplasms malignant and unspecified | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:skin appendage tumors may show malignant transformation ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:skin appendage tumors may show malignant transformation | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:skin basal cell carcinoma ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:skin basal cell carcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:skin hemangioma ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:skin hemangioma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:small intestine carcinoid ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:small intestine carcinoid | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:soft tissue tumor and/or sarcoma ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:soft tissue tumor and/or sarcoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:susceptibility to myelodysplasia ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:susceptibility to myelodysplasia | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:thyroid cancer, follicular variant papillary ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:thyroid cancer, follicular variant papillary | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:vestibular schwannoma (over 90% of patients) ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=en:vestibular schwannoma (over 90% of patients) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- myxoma ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=myxoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- mésothéliome ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=mésothéliome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- épithélioma sébacé ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=épithélioma sébacé | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- état prénéoplasique ---
r_associated #0: 35 -->
en:sebaceous epithelioma
n1=état prénéoplasique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:ampulla of vater adenocarcinoma ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:ampulla of vater adenocarcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:astrocytoma, increased risk of ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:astrocytoma, increased risk of | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:benign soft tissue neoplasm ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:benign soft tissue neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:carotid body paraganglioma ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:carotid body paraganglioma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:dermoid cyst of the skin ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:dermoid cyst of the skin | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:gastrointestinal neoplasms malignant and unspecified ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:gastrointestinal neoplasms malignant and unspecified | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:glioma, increased risk of ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:glioma, increased risk of | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:gonadoblastoma ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:gonadoblastoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:granular cell tumor and/or alveolar soft part sarcoma ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:granular cell tumor and/or alveolar soft part sarcoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:increased malignancy risk, especially lymphoma and skin neoplasm ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:increased malignancy risk, especially lymphoma and skin neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:increased susceptibility to cancer ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:increased susceptibility to cancer | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:junctional nevus ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:junctional nevus | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:laryngeal carcinoma ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:laryngeal carcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:low-grade neuroendocrine carcinoma (submandibular glands, salivary glands, maxillary sinus, nasal cavity) ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:low-grade neuroendocrine carcinoma (submandibular glands, salivary glands, maxillary sinus, nasal cavity) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:malignancy in approximately 10% ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:malignancy in approximately 10% | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:malignant breast neoplasm ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:malignant breast neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:malignant genitourinary tract tumor ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:malignant genitourinary tract tumor | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:myopericytoma of skin ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:myopericytoma of skin | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:neoplasm of uncertain behavior of other and unspecified sites and tissues ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:neoplasm of uncertain behavior of other and unspecified sites and tissues | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:no cancer despite harboring complete deletions of the tp53 gene ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:no cancer despite harboring complete deletions of the tp53 gene | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:nonmedullary thyroid carcinoma (papillary and follicular) ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:nonmedullary thyroid carcinoma (papillary and follicular) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:odontogenic neoplasm ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:odontogenic neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:osteosarcoma ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:osteosarcoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:paragangliomas, head and neck (79%) ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:paragangliomas, head and neck (79%) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:pheochromocytomas, extraadrenal (48%) ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:pheochromocytomas, extraadrenal (48%) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:sinonasal undifferentiated carcinoma ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:sinonasal undifferentiated carcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:skin cysts and polyps ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:skin cysts and polyps | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:thyroid gland oncocytic neoplasm ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:thyroid gland oncocytic neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:unilateral vestibular schwannoma ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=en:unilateral vestibular schwannoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- leucémie lymphoïde chronique ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=leucémie lymphoïde chronique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- névrome cutané ---
r_associated #0: 34 -->
en:sebaceous epithelioma
n1=névrome cutané | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=34
- en:chronic lymphocytic leukemia ---
r_associated #0: 33 -->
en:sebaceous epithelioma
n1=en:chronic lymphocytic leukemia | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=33
- en:follicular lymphoma ---
r_associated #0: 33 -->
en:sebaceous epithelioma
n1=en:follicular lymphoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=33
- en:mesothelioma ---
r_associated #0: 33 -->
en:sebaceous epithelioma
n1=en:mesothelioma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=33
- nævus de Sutton ---
r_associated #0: 33 -->
en:sebaceous epithelioma
n1=nævus de Sutton | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=33
- ostéosarcome ---
r_associated #0: 33 -->
en:sebaceous epithelioma
n1=ostéosarcome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=33
- chordome ---
r_associated #0: 32 -->
en:sebaceous epithelioma
n1=chordome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=32
- en:abdominal tumors (immunodeficiency-associated form) ---
r_associated #0: 32 -->
en:sebaceous epithelioma
n1=en:abdominal tumors (immunodeficiency-associated form) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=32
- en:cyst ---
r_associated #0: 32 -->
en:sebaceous epithelioma
n1=en:cyst | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=32
- en:duodenal carcinoma ---
r_associated #0: 32 -->
en:sebaceous epithelioma
n1=en:duodenal carcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=32
- en:endocrine neoplasms malignant and unspecified ---
r_associated #0: 32 -->
en:sebaceous epithelioma
n1=en:endocrine neoplasms malignant and unspecified | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=32
- en:esophageal carcinoma ---
r_associated #0: 32 -->
en:sebaceous epithelioma
n1=en:esophageal carcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=32
- en:halo nevus ---
r_associated #0: 32 -->
en:sebaceous epithelioma
n1=en:halo nevus | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=32
- en:kaposi sarcoma (1 patient) ---
r_associated #0: 32 -->
en:sebaceous epithelioma
n1=en:kaposi sarcoma (1 patient) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=32
- en:metastatic angiosarcoma ---
r_associated #0: 32 -->
en:sebaceous epithelioma
n1=en:metastatic angiosarcoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=32
- en:multiple bilateral renal angiomyolipoma ---
r_associated #0: 32 -->
en:sebaceous epithelioma
n1=en:multiple bilateral renal angiomyolipoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=32
- en:multiple schwannomas ---
r_associated #0: 32 -->
en:sebaceous epithelioma
n1=en:multiple schwannomas | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=32
- en:ovarian cystadenoma ---
r_associated #0: 32 -->
en:sebaceous epithelioma
n1=en:ovarian cystadenoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=32
- en:pancreatic squamous cell carcinoma ---
r_associated #0: 32 -->
en:sebaceous epithelioma
n1=en:pancreatic squamous cell carcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=32
- en:pinealoma (trilateral retinoblastoma) ---
r_associated #0: 32 -->
en:sebaceous epithelioma
n1=en:pinealoma (trilateral retinoblastoma) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=32
- en:reported colon and other abdominal cancer in relatives ---
r_associated #0: 32 -->
en:sebaceous epithelioma
n1=en:reported colon and other abdominal cancer in relatives | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=32
- en:sacrococcygeal teratoma ---
r_associated #0: 32 -->
en:sebaceous epithelioma
n1=en:sacrococcygeal teratoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=32
- en:sex cord-stromal tumor ---
r_associated #0: 32 -->
en:sebaceous epithelioma
n1=en:sex cord-stromal tumor | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=32
- en:soft tissue neoplasms malignant and unspecified ---
r_associated #0: 32 -->
en:sebaceous epithelioma
n1=en:soft tissue neoplasms malignant and unspecified | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=32
- non précisée, tumeur maligne de l'oesophage ---
r_associated #0: 32 -->
en:sebaceous epithelioma
n1=non précisée, tumeur maligne de l'oesophage | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=32
- pancréas (cancer du) ---
r_associated #0: 32 -->
en:sebaceous epithelioma
n1=pancréas (cancer du) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=32
- en:acute megakaryoblastic leukemia ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:acute megakaryoblastic leukemia | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:benign endocrine neoplasm ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:benign endocrine neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:benign neoplasm of skin of head and neck ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:benign neoplasm of skin of head and neck | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:bone metastases from squamous cell carcinoma ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:bone metastases from squamous cell carcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:chronic lymphocytic leukemia, b-cell, susceptibility to ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:chronic lymphocytic leukemia, b-cell, susceptibility to | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:colorectal cancer, early onset ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:colorectal cancer, early onset | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:cutaneous leiomyosarcoma (less common) ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:cutaneous leiomyosarcoma (less common) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:cutaneous lipoma ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:cutaneous lipoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:cylindromas may show malignant transformation ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:cylindromas may show malignant transformation | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:hypothalamic neoplasm ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:hypothalamic neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:increased hepatocellular carcinoma risk ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:increased hepatocellular carcinoma risk | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:increased risk in heterozygotes ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:increased risk in heterozygotes | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:increased risk of chondrosarcoma (mean age of onset 31 years) ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:increased risk of chondrosarcoma (mean age of onset 31 years) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:increased risk of giant cell tumor of bone ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:increased risk of giant cell tumor of bone | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:increased risk of meningioma ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:increased risk of meningioma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:increased susceptibility to malignancy ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:increased susceptibility to malignancy | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:malignant tumor, clear cell type ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:malignant tumor, clear cell type | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:neoplasm by morphology ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:neoplasm by morphology | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:neoplasm/cancer invasiveness ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:neoplasm/cancer invasiveness | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:neoplasms of unspecified nature or uncertain behavior ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:neoplasms of unspecified nature or uncertain behavior | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:neuroblastoma, arises anywhere along the sympathetic chain (including intracranially) ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:neuroblastoma, arises anywhere along the sympathetic chain (including intracranially) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:neuroepitheliomatous neoplasm ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:neuroepitheliomatous neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:paraneoplastic sps is associated with autoantibodies to amphiphysin (amph, 600418) ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:paraneoplastic sps is associated with autoantibodies to amphiphysin (amph, 600418) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:periampullary carcinoma nos ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:periampullary carcinoma nos | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:phyllodes tumor ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:phyllodes tumor | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:pigmented nevus ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:pigmented nevus | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:pleomorphic benign salivary gland adenoma (psa) ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:pleomorphic benign salivary gland adenoma (psa) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:propensity to tumor development ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:propensity to tumor development | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:renal and urinary tract neoplasms malignant and unspecified ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:renal and urinary tract neoplasms malignant and unspecified | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:seborrheic keratosis ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:seborrheic keratosis | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:small cell carcinoma of the ovary, hypercalcemic type ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:small cell carcinoma of the ovary, hypercalcemic type | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- en:teratoid tumor, atypical ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=en:teratoid tumor, atypical | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- ganglioneurome ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=ganglioneurome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- kératose séborrhéique ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=kératose séborrhéique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- naevus bleu ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=naevus bleu | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- naevus mixte ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=naevus mixte | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- ostéome cutané ---
r_associated #0: 31 -->
en:sebaceous epithelioma
n1=ostéome cutané | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=31
- angiome ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=angiome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- blastome ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=blastome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- cancer embryonnaire ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=cancer embryonnaire | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- cancer oculaire ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=cancer oculaire | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- cancer sébacé ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=cancer sébacé | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:acrochordon ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:acrochordon | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:acute lymphoblastic leukemia (in 1 patient) ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:acute lymphoblastic leukemia (in 1 patient) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:benign male reproductive system neoplasm ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:benign male reproductive system neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:benign neoplasm of skin of hip and lower limb ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:benign neoplasm of skin of hip and lower limb | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:benign neoplasm of skin of lip ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:benign neoplasm of skin of lip | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:benign tumor ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:benign tumor | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:birt-hogg-dube syndrome ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:birt-hogg-dube syndrome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:brain neoplasm ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:brain neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:classic hodgkin lymphoma (in some patients) ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:classic hodgkin lymphoma (in some patients) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:cutaneous granular cell tumor ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:cutaneous granular cell tumor | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:enteropathy-associated t-cell lymphoma ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:enteropathy-associated t-cell lymphoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:fibroelastoma ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:fibroelastoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:gangliocytoneuroma ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:gangliocytoneuroma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:ganglioneuroma ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:ganglioneuroma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:giant cell tumor ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:giant cell tumor | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:increased incidence of hepatocellular carcinoma ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:increased incidence of hepatocellular carcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:increased risk for cancer ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:increased risk for cancer | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:increased risk of breast cancer in women ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:increased risk of breast cancer in women | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:increased risk of leukemia ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:increased risk of leukemia | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:increased risk of testicular cancer ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:increased risk of testicular cancer | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:increased susceptibility to multiple carcinomas ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:increased susceptibility to multiple carcinomas | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:lymphoproliferative disorder ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:lymphoproliferative disorder | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:malignant tumor of lymphoid hemopoietic and related tissue ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:malignant tumor of lymphoid hemopoietic and related tissue | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:mesothelioma, malignant, after asbestos exposure ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:mesothelioma, malignant, after asbestos exposure | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:multiple tumors in 74% of patients ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:multiple tumors in 74% of patients | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:neoplasms by histologic type ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:neoplasms by histologic type | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:nervous system neoplasms malignant and unspecified nec ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:nervous system neoplasms malignant and unspecified nec | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:nervous system tumor morphology ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:nervous system tumor morphology | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:osteoma cutis ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:osteoma cutis | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:silicon granuloma ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:silicon granuloma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:somatostatin-producing neuroendocrine tumor ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:somatostatin-producing neuroendocrine tumor | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:thyroid gland papillary carcinoma ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:thyroid gland papillary carcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:tumor cells, benign ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:tumor cells, benign | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:tumors of the sympathetic nervous system (5 to 10%) ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=en:tumors of the sympathetic nervous system (5 to 10%) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- naevus de spitz ---
r_associated #0: 30 -->
en:sebaceous epithelioma
n1=naevus de spitz | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=30
- en:Hodgkin lymphoma ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:Hodgkin lymphoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:adrenal gland pheochromocytoma ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:adrenal gland pheochromocytoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:alveolar cell carcinoma (some) ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:alveolar cell carcinoma (some) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:b-cell acute lymphoblastic leukemia (in some patients) ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:b-cell acute lymphoblastic leukemia (in some patients) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:basal cell nevus ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:basal cell nevus | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:benign neoplasm of scalp and skin of neck ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:benign neoplasm of scalp and skin of neck | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:colloid tumor ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:colloid tumor | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:dermatofibroma ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:dermatofibroma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:glioneuroma ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:glioneuroma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:increased risk of malignancy ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:increased risk of malignancy | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:increased risk of other cancers (e.g., kidney cancer, lung cancer, and leukemia) ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:increased risk of other cancers (e.g., kidney cancer, lung cancer, and leukemia) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:leser-trélat sign ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:leser-trélat sign | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:malignant fibrous histiocytoma (in about 35% of patients) ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:malignant fibrous histiocytoma (in about 35% of patients) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:malignant neoplasm of bone, connective tissue, skin and breast ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:malignant neoplasm of bone, connective tissue, skin and breast | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:malignant peripheral nerve sheath tumor ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:malignant peripheral nerve sheath tumor | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:malignant transformation of choroid plexus papilloma ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:malignant transformation of choroid plexus papilloma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:miscellaneous and site unspecified neoplasms malignant and unspecified ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:miscellaneous and site unspecified neoplasms malignant and unspecified | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:monomorphic cells, medium-sized, with round nuclei, multiple nucleoli, and moderate amount of cytoplasm ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:monomorphic cells, medium-sized, with round nuclei, multiple nucleoli, and moderate amount of cytoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:mucosal neuromas ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:mucosal neuromas | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:muir-torre syndrome ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:muir-torre syndrome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:myxoblastoma ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:myxoblastoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:neoplasms of uncertain or unknown behaviour ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:neoplasms of uncertain or unknown behaviour | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:neuronal or mixed neuronal-glial neoplasm ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:neuronal or mixed neuronal-glial neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:pheochromocytomas, adrenal (28%) ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:pheochromocytomas, adrenal (28%) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:primary adrenocortical nodular hyperplasia ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:primary adrenocortical nodular hyperplasia | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:rarely malignant ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:rarely malignant | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:respiratory and mediastinal neoplasms benign (excl mesotheliomas) ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:respiratory and mediastinal neoplasms benign (excl mesotheliomas) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:susceptibility to malignant melanoma ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:susceptibility to malignant melanoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- en:testicular sertoli cell tumor, calcified ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=en:testicular sertoli cell tumor, calcified | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- leucémie lymphoïde aiguë ---
r_associated #0: 29 -->
en:sebaceous epithelioma
n1=leucémie lymphoïde aiguë | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
- Méningiomes ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=Méningiomes | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- adénosarcome sébacé ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=adénosarcome sébacé | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- cancer à cellules claires du rein ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=cancer à cellules claires du rein | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- carcinome sébacé ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=carcinome sébacé | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:accelerated neoplasm growth ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:accelerated neoplasm growth | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:adrenal cortex carcinoma ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:adrenal cortex carcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:benign female reproductive system neoplasm ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:benign female reproductive system neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:benign neoplasm of eyelid including canthus ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:benign neoplasm of eyelid including canthus | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:bladder urothelial carcinoma ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:bladder urothelial carcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:bowenoid papulosis ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:bowenoid papulosis | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:bronchogenic carcinoma (some) ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:bronchogenic carcinoma (some) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:cervical cancer (rare) ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:cervical cancer (rare) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:clear cell neoplasm ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:clear cell neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:colon carcinoma ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:colon carcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:epithelial neoplasm ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:epithelial neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:extra-adrenal sympathetic paraganglioma ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:extra-adrenal sympathetic paraganglioma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:gastric adenocarcinoma ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:gastric adenocarcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:giant cell astrocytoma ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:giant cell astrocytoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:glandular carcinoma ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:glandular carcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:growth hormone-producing pituitary gland neoplasm ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:growth hormone-producing pituitary gland neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:hepatobiliary neoplasms malignant and unspecified ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:hepatobiliary neoplasms malignant and unspecified | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:hodgkin lymphoma ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:hodgkin lymphoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:increased risk of gastrointestinal cancer ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:increased risk of gastrointestinal cancer | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:increased risk of pancreatic cancer ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:increased risk of pancreatic cancer | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:increased susceptibility to carcinomas, especially cancers related to cutaneous viral infections ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:increased susceptibility to carcinomas, especially cancers related to cutaneous viral infections | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:jaw and kidney tumor (endemic form) ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:jaw and kidney tumor (endemic form) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:low incidence of plexiform neurofibromas ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:low incidence of plexiform neurofibromas | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:malignant sex cord-stromal tumor ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:malignant sex cord-stromal tumor | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:malignant spindle cell neoplasm ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:malignant spindle cell neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:multiple tumors ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:multiple tumors | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:neoplasm of perivascular myoid type - category ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:neoplasm of perivascular myoid type - category | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:oropharyngeal squamous cell carcinoma ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:oropharyngeal squamous cell carcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:ovarian carcinoma ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:ovarian carcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:ovarian sex cord-stromal tumor ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:ovarian sex cord-stromal tumor | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:parathyroid gland carcinoma ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:parathyroid gland carcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:pheochromocytoma, adrenal (53%) ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:pheochromocytoma, adrenal (53%) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:renal cortical adenoma ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:renal cortical adenoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- en:subependymoma ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=en:subependymoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- tumeur maligne du côlon non précisée ---
r_associated #0: 28 -->
en:sebaceous epithelioma
n1=tumeur maligne du côlon non précisée | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=28
- cancer du sein ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=cancer du sein | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:acute lymphoblastic leukemia ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:acute lymphoblastic leukemia | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:basocellular neoplasms develop after second decade ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:basocellular neoplasms develop after second decade | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:benign digestive system neoplasm ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:benign digestive system neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:breast neoplasms benign (incl nipple) ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:breast neoplasms benign (incl nipple) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:classic hodgkin lymphoma ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:classic hodgkin lymphoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:colorectal cancer (in some patients) ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:colorectal cancer (in some patients) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:cystic, mucinous and/or serous neoplasm ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:cystic, mucinous and/or serous neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:digestive system neoplasms ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:digestive system neoplasms | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:endolymphatic sac tumor ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:endolymphatic sac tumor | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:frequent skin cancer ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:frequent skin cancer | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:increased risk of endometrial cancer ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:increased risk of endometrial cancer | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:intradermal nevus ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:intradermal nevus | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:lipomatous neoplasm ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:lipomatous neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:lobular hemangioma ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:lobular hemangioma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:lung adenocarcinoma ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:lung adenocarcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:malignant digestive system neoplasm ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:malignant digestive system neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:malignant peripheral nerve sheath tumors (21%) ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:malignant peripheral nerve sheath tumors (21%) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:malignant thyroid gland neoplasm ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:malignant thyroid gland neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:mammary ductal fibroadenoma ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:mammary ductal fibroadenoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:melanocytic neoplasm ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:melanocytic neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:multinucleate cell angiohistiocytoma ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:multinucleate cell angiohistiocytoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:myomatous neoplasm ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:myomatous neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:neoplasm of uncertain behavior of endocrine glands and nervous system ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:neoplasm of uncertain behavior of endocrine glands and nervous system | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:optic nerve glioma ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:optic nerve glioma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:papillary neoplasm ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:papillary neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:radiation-related neoplasm ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:radiation-related neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:respiratory and mediastinal neoplasms malignant and unspecified ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:respiratory and mediastinal neoplasms malignant and unspecified | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:sebaceoma ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:sebaceoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:signet ring cell carcinoma ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:signet ring cell carcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:skin carcinoma ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:skin carcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:spindle cell sarcoma ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:spindle cell sarcoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:thyroid cancer (follicular cell) ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:thyroid cancer (follicular cell) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:uterine leiomyosarcoma (less common) ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=en:uterine leiomyosarcoma (less common) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- sébacéome ---
r_associated #0: 27 -->
en:sebaceous epithelioma
n1=sébacéome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=27
- en:angioneoplasm ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:angioneoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:benign tumor of dermis ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:benign tumor of dermis | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:bone-forming neoplasm ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:bone-forming neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:breast cancer (rare) ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:breast cancer (rare) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:breast carcinoma ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:breast carcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:burkitt lymphoma (b-cell lymphoma) ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:burkitt lymphoma (b-cell lymphoma) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:cervical carcinoma ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:cervical carcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:clear cell renal cell carcinoma ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:clear cell renal cell carcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:desmocytoma ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:desmocytoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:head and neck paraganglioma ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:head and neck paraganglioma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:hereditary neoplastic syndrome ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:hereditary neoplastic syndrome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:increased risk for hematologic cancer, particularly acute myeloid leukemia ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:increased risk for hematologic cancer, particularly acute myeloid leukemia | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:increased risk of chondrosarcoma ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:increased risk of chondrosarcoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:jugulotympanic paraganglioma ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:jugulotympanic paraganglioma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:juvenile ovarian granulosa cell tumor ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:juvenile ovarian granulosa cell tumor | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:malignant neoplasm of digestive organs and peritoneum ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:malignant neoplasm of digestive organs and peritoneum | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:malignant pharyngeal neoplasm ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:malignant pharyngeal neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:mucous tumor ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:mucous tumor | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:multiple giant cell granulomas (bones, joints, soft tissues) ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:multiple giant cell granulomas (bones, joints, soft tissues) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:multiple tumors in 28% of patients ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:multiple tumors in 28% of patients | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:myocardial rhabdomyoma ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:myocardial rhabdomyoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:myxoid subcutaneous tumors ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:myxoid subcutaneous tumors | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:neoplasm of unspecified nature of bone, soft tissue, and skin ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:neoplasm of unspecified nature of bone, soft tissue, and skin | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:neoplasms, multiple primary ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:neoplasms, multiple primary | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:neural tissue tumors ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:neural tissue tumors | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:neuroblastoma (less common) ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:neuroblastoma (less common) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:paragangliomas, head and neck (31%) ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:paragangliomas, head and neck (31%) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:parathyroid gland adenoma ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:parathyroid gland adenoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:parotid gland adenoma and adenocarcinoma ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:parotid gland adenoma and adenocarcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:rhabdoid tumors, malignant (renal or extrarenal) ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:rhabdoid tumors, malignant (renal or extrarenal) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:skin - benign mole and nevus ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:skin - benign mole and nevus | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:squamous cell carcinoma in area of palmoplantar keratoderma (rare) ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:squamous cell carcinoma in area of palmoplantar keratoderma (rare) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:starry sky pattern ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:starry sky pattern | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:statistical association of extensive metabolism (em, wildtype) and malignancy, especially smoking-induced lung cancer ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:statistical association of extensive metabolism (em, wildtype) and malignancy, especially smoking-induced lung cancer | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- en:susceptibility to myeloid leukemia ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=en:susceptibility to myeloid leukemia | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- tumeur de Grawitz ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=tumeur de Grawitz | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- tumeur maligne de l'oesophage non précisée ---
r_associated #0: 26 -->
en:sebaceous epithelioma
n1=tumeur maligne de l'oesophage non précisée | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=26
- LaM ---
r_associated #0: 25 -->
en:sebaceous epithelioma
n1=LaM | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=25
- en:acoustic neuroma ---
r_associated #0: 25 -->
en:sebaceous epithelioma
n1=en:acoustic neuroma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=25
- en:carcinoma in situ ---
r_associated #0: 25 -->
en:sebaceous epithelioma
n1=en:carcinoma in situ | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=25
- en:malignant neurinoma ---
r_associated #0: 25 -->
en:sebaceous epithelioma
n1=en:malignant neurinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=25
- en:malignant tumor of eye ---
r_associated #0: 25 -->
en:sebaceous epithelioma
n1=en:malignant tumor of eye | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=25
- en:neurilemoma ---
r_associated #0: 25 -->
en:sebaceous epithelioma
n1=en:neurilemoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=25
- carcinome rénal à cellules claires ---
r_associated #0: 24 -->
en:sebaceous epithelioma
n1=carcinome rénal à cellules claires | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=24
- en:benign neoplasm of skin of upper limb or shoulder nos ---
r_associated #0: 24 -->
en:sebaceous epithelioma
n1=en:benign neoplasm of skin of upper limb or shoulder nos | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=24
- en:malignant neoplasm of duodenum ---
r_associated #0: 24 -->
en:sebaceous epithelioma
n1=en:malignant neoplasm of duodenum | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=24
- carcinome embryonnaire ---
r_associated #0: 23 -->
en:sebaceous epithelioma
n1=carcinome embryonnaire | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=23
- en:colorectal cancer ---
r_associated #0: 23 -->
en:sebaceous epithelioma
n1=en:colorectal cancer | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=23
- en:gelatinous tumor ---
r_associated #0: 23 -->
en:sebaceous epithelioma
n1=en:gelatinous tumor | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=23
- en:malignant tumor, small cell type ---
r_associated #0: 23 -->
en:sebaceous epithelioma
n1=en:malignant tumor, small cell type | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=23
- en:peripheral glioma ---
r_associated #0: 23 -->
en:sebaceous epithelioma
n1=en:peripheral glioma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=23
- bowénoïde (papulose) ---
r_associated #0: 22 -->
en:sebaceous epithelioma
n1=bowénoïde (papulose) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=22
- condylome acuminé ---
r_associated #0: 22 -->
en:sebaceous epithelioma
n1=condylome acuminé | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=22
- en:becker nevus ---
r_associated #0: 22 -->
en:sebaceous epithelioma
n1=en:becker nevus | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=22
- en:benign neoplasm: skin of other and unspecified parts of face ---
r_associated #0: 22 -->
en:sebaceous epithelioma
n1=en:benign neoplasm: skin of other and unspecified parts of face | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=22
- en:malignant neoplasms of respiratory and intrathoracic organs ---
r_associated #0: 22 -->
en:sebaceous epithelioma
n1=en:malignant neoplasms of respiratory and intrathoracic organs | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=22
- en:soft wart ---
r_associated #0: 22 -->
en:sebaceous epithelioma
n1=en:soft wart | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=22
- leucémie aiguë lymphoïde ---
r_associated #0: 22 -->
en:sebaceous epithelioma
n1=leucémie aiguë lymphoïde | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=22
- adénocarcinome gastrique ---
r_associated #0: 21 -->
en:sebaceous epithelioma
n1=adénocarcinome gastrique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=21
- en:malignant neoplasm of lip, oral cavity and pharynx ---
r_associated #0: 21 -->
en:sebaceous epithelioma
n1=en:malignant neoplasm of lip, oral cavity and pharynx | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=21
- en:neoplasm of unspecified nature of other genitourinary organs ---
r_associated #0: 21 -->
en:sebaceous epithelioma
n1=en:neoplasm of unspecified nature of other genitourinary organs | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=21
- leucémie aiguë lymphoblastique ---
r_associated #0: 21 -->
en:sebaceous epithelioma
n1=leucémie aiguë lymphoblastique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=21
- mesothéliome ---
r_associated #0: 21 -->
en:sebaceous epithelioma
n1=mesothéliome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=21
- Leucémie myéloïde aiguë ---
r_associated #0: 20 -->
en:sebaceous epithelioma
n1=Leucémie myéloïde aiguë | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=20
- Lipome ---
r_associated #0: 20 -->
en:sebaceous epithelioma
n1=Lipome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=20
- Rétinoblastome ---
r_associated #0: 20 -->
en:sebaceous epithelioma
n1=Rétinoblastome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=20
- Cancer de l'oesophage ---
r_associated #0: 15 -->
en:sebaceous epithelioma
n1=Cancer de l'oesophage | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=15
- Cancer du sang ---
r_associated #0: 15 -->
en:sebaceous epithelioma
n1=Cancer du sang | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=15
- Cancer du sein ---
r_associated #0: 15 -->
en:sebaceous epithelioma
n1=Cancer du sein | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=15
- Chordome ---
r_associated #0: 15 -->
en:sebaceous epithelioma
n1=Chordome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=15
- Hémangiome ---
r_associated #0: 15 -->
en:sebaceous epithelioma
n1=Hémangiome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=15
- LLC
(médecine) ---
r_associated #0: 15 -->
en:sebaceous epithelioma
n1=LLC (médecine) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=15
- Leucémie aiguë lymphoblastique ---
r_associated #0: 15 -->
en:sebaceous epithelioma
n1=Leucémie aiguë lymphoblastique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=15
- Leucémie aigüe myéloïde ---
r_associated #0: 15 -->
en:sebaceous epithelioma
n1=Leucémie aigüe myéloïde | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=15
- Leucémie lymphoïde chronique ---
r_associated #0: 15 -->
en:sebaceous epithelioma
n1=Leucémie lymphoïde chronique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome ---
r_associated #0: 15 -->
en:sebaceous epithelioma
n1=Ostéosarcome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=15
- Tumeurs du pancréas ---
r_associated #0: 15 -->
en:sebaceous epithelioma
n1=Tumeurs du pancréas | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=15
- adénine-phosphoribosyltransférase (APRTase) (déficit en) ---
r_associated #0: 15 -->
en:sebaceous epithelioma
n1=adénine-phosphoribosyltransférase (APRTase) (déficit en) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=15
- chronique leucémie lymphoïde ---
r_associated #0: 15 -->
en:sebaceous epithelioma
n1=chronique leucémie lymphoïde | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=15
- dermatitis nodularis necrotica (ou necroticans ) ---
r_associated #0: 15 -->
en:sebaceous epithelioma
n1=dermatitis nodularis necrotica (ou necroticans ) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=15
- en:vascular tumor ---
r_associated #0: 15 -->
en:sebaceous epithelioma
n1=en:vascular tumor | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=15
- fibromyalgie (critères de l' American College of Rheumatology ) ---
r_associated #0: 15 -->
en:sebaceous epithelioma
n1=fibromyalgie (critères de l' American College of Rheumatology ) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=15
- gliome (classifications de l'OMS) ---
r_associated #0: 15 -->
en:sebaceous epithelioma
n1=gliome (classifications de l'OMS) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=15
- LLC ---
r_associated #0: 11 -->
en:sebaceous epithelioma
n1=LLC | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=11
- Cancer colorectal ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=Cancer colorectal | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- Cancer de l'endomètre ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=Cancer de l'endomètre | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- Cancer du côlon ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=Cancer du côlon | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- Cancer duodénal ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=Cancer duodénal | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- Cancers ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=Cancers | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- Chopart (désarticulation de) ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=Chopart (désarticulation de) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- LANL ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=LANL | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- Leucémie ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=Leucémie | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- Leucémie aiguë myéloblastique ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=Leucémie aiguë myéloblastique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- Lung ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=Lung | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- Melanoma ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=Melanoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- Mélanome ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=Mélanome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- Méningiome ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=Méningiome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- Mésothéliome ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=Mésothéliome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- Sarcome ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=Sarcome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- Schwann (gaine de) ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=Schwann (gaine de) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- cachexie maligne ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=cachexie maligne | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- crabes ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=crabes | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- cyst ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=cyst | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- en:acoustic neurinoma ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=en:acoustic neurinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- en:acute lymphocytic leukemia ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=en:acute lymphocytic leukemia | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- en:adipose wen ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=en:adipose wen | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- en:and endocrine overactivity ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=en:and endocrine overactivity | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- en:angioma ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=en:angioma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- en:bone sarcoma ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=en:bone sarcoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- en:breastcancer ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=en:breastcancer | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- en:cancer of the breast ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=en:cancer of the breast | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- en:cancer of the colon ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=en:cancer of the colon | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- en:cancer of the oesophagus ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=en:cancer of the oesophagus | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- en:carcinoma of colon ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=en:carcinoma of colon | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- en:carcinoma of the breast ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=en:carcinoma of the breast | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- en:chronic lymphocytic leukaemia ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=en:chronic lymphocytic leukaemia | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- en:chronic lymphoid leukemia ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=en:chronic lymphoid leukemia | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- en:colon malignancy ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=en:colon malignancy | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- en:dermatitis nodularis necrotica ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=en:dermatitis nodularis necrotica | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- en:fatty tumor ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=en:fatty tumor | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- en:fatty tumour ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=en:fatty tumour | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- en:fibroma molle ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=en:fibroma molle | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- en:in situ cancer ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=en:in situ cancer | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- en:lymphocytic leukaemia ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=en:lymphocytic leukaemia | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- en:malignant duodenal neoplasm ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=en:malignant duodenal neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- en:mastocarcinoma ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=en:mastocarcinoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- en:oesophageal cancer ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=en:oesophageal cancer | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- en:spotty pigmentation ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=en:spotty pigmentation | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- en:venereal wart ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=en:venereal wart | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- en:« osteogenic » sarcoma ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=en:« osteogenic » sarcoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- fibrome cutané ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=fibrome cutané | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- histiocytofibrome ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=histiocytofibrome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- malignité ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=malignité | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- myxoïde (dégénérescence) ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=myxoïde (dégénérescence) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- myélome (manifestations rénales du) ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=myélome (manifestations rénales du) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- mélanisation (unité épidermique de) ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=mélanisation (unité épidermique de) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- méningé (syndrome) ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=méningé (syndrome) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- neurinome bilatéral du nerf cochléaire (VIII) ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=neurinome bilatéral du nerf cochléaire (VIII) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- sarcoïde de Spiegler-Fendt (sarcoïde de ) ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=sarcoïde de Spiegler-Fendt (sarcoïde de ) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- siège primitif inconnu ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=siège primitif inconnu | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- skin peeling (syndrome) ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=skin peeling (syndrome) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- tumeur à cellules folliculaires thyroïdiennes ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=tumeur à cellules folliculaires thyroïdiennes | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- étalement(d&apos,uneirradiation) ---
r_associated #0: 10 -->
en:sebaceous epithelioma
n1=étalement(d&apos,uneirradiation) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=10
- gliome du nerf optique ---
r_associated #0: 6 -->
en:sebaceous epithelioma
n1=gliome du nerf optique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=6
- Angiome ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=Angiome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- Carcinome colorectal ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=Carcinome colorectal | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- Dermatobia hominis ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=Dermatobia hominis | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- Letterer-Siwe (maladie de) ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=Letterer-Siwe (maladie de) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- adéno-acanthome du col utérin ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=adéno-acanthome du col utérin | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- adénoacanthome ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=adénoacanthome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- adénoaméloblastome ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=adénoaméloblastome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- carcinome intra-épithélial ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=carcinome intra-épithélial | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- dermatitis repens de Crocker ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=dermatitis repens de Crocker | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- dermatoarthrite lipoïdique ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=dermatoarthrite lipoïdique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- dermatochalasis généralisé ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=dermatochalasis généralisé | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- dermatochalazie granulomateuse ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=dermatochalazie granulomateuse | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- déficit en adénine-phosphoribosyltransférase ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=déficit en adénine-phosphoribosyltransférase | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- en:angiome ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=en:angiome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- en:colon cancer ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=en:colon cancer | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- fibroplastique ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=fibroplastique | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- gliome de haut grade ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=gliome de haut grade | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- gliome de l'utérus ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=gliome de l'utérus | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- gliome des voies optiques ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=gliome des voies optiques | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- gliome du chiasma ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=gliome du chiasma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- gliome malin du nerf optique et du chiasma ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=gliome malin du nerf optique et du chiasma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- gliome nasal ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=gliome nasal | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- gliome papillaire ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=gliome papillaire | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- leucémie aigüe myéloblastique (LAM) : stratification de risques ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=leucémie aigüe myéloblastique (LAM) : stratification de risques | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- ostéoporose-pseudogliome (syndrome) ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=ostéoporose-pseudogliome (syndrome) | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- pancréas aberrant ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=pancréas aberrant | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- pancréas accessoire ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=pancréas accessoire | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- pancréas annulaire ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=pancréas annulaire | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- pancréas artificiel ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=pancréas artificiel | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- pancréas de Willis ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=pancréas de Willis | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- pancréas de Winslow ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=pancréas de Winslow | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- pancréas divisum ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=pancréas divisum | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- pancréastatine ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=pancréastatine | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
- tumeurs à plusieurs autres sites, y compris le système nerveux central ---
r_associated #0: 5 -->
en:sebaceous epithelioma
n1=tumeurs à plusieurs autres sites, y compris le système nerveux central | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=5
|